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I. INTRODUCTION

The Relevance of Genetics to Medicine
This issue of the MCV Quarterly focuses on the
explosion of knowledge in the field of human genetics. The activities of the new Department of Human
Genetics at the Medical College of Virginia encompass the traditional medical school triad of teaching,
patient care, and research, and an active graduate
program has been developed with curricula leading
to masters a nd doctorate degrees. The program is
supported by a recently awarded National Institutes
of Health predoctoral training grant as well as State
and local funds from the A. D. Williams Foundation.
Clinical services are provided in a National
Foundation-March of Dimes Genetic Counseling
Clinic and through an interdepartmental Antenatal
Diagnosis Program . At present, however, as shown
by some of the case reports in this issue, resea rch and
clinical service are inextricably intertwined.
There has, perhaps, been no recent advance in
medical technology that has greater potential for improving the human condition than the development
of reliable methods for the prenatal diagnosis of a
growing list of specific genetic diseases. The Antenatal Diagnosis Program at MCV has been developed with suppport from the State Department of
Health and has at its disposal the most modern"
equipment available for these test procedures. N eona ta I screening for genetic disease and carrier detection programs are two logical complements to prenatal diagnosis.
It is becoming increasingly clear that the major
causes of morbidity and mortality in Western cultures a re neither entirely environmental nor genetic
in etiology but result, rather, from an interaction between the host and a pathogenic agent in a constantly
changing environment. The concept of genetic risk
factors may well emerge as the most significant and
effective new health care strategy to appear during
the last quarter of this century. Experience with the
treatment of genetically determined metabolic diseases suggests that when a specific genetic liability
can be diagnosed, patients and their parents are in

general highly motivated to comply even with extremely elaborate treatment regimes. Wouldn't a n
individual who had seen a parent or close relative die
of hypertension, heart disease, cancer, or pulmonary
disease have a strong motivation to comply with a
program of presymptomatic screening and treatment
if he or she could be shown to carry a specific genetic
risk factor? Improved public education will be essential for the acceptance of this approach to disease
prevention. Since all normal individuals carry abnormal recessive genes, the diagnosis of a genetic disease
or carrier state in a family should not be viewed as a
stigma but rather as a readily identifiable risk factor
that can be exploited by the prudent physician to plan
a highly individualized health maintenance program
for the patient. At present, relatively few alleles have
been identified which can be detected in the heterozygous state that are associated with an increased
disease risk; however, the number is growing, and it
seems likely that this will continue to be a very active
area of research in the future.
Genetic diseases are estimated to acco unt for
15% of all pediatric hospital admissions. Recognizable chromosome abnormalities acco unt for more
than 50% of all early spontaneous first trimester abortions. A single genetic disease, Usher syndrome, accounts for more than 60% of all adults seeking rehabilitative services for the combined handicap of
deafness and blindness. The lifetime cost of caring for
the 3,000 to 4,000 new children who a re born each
year with Down syndrome is estimated to be in excess
of $60,000,000 per year. More than 2,000 genetic diseases have now been described, most within the past
two decades, and at least one genetic locus has now
been mapped to each of the 23 pairs of chromosomes,
most within the past two years. These facts presage
the increasingly important role that genetics will play
in medicine an d hum an affairs in future years.
WALTER E. NANCE, M.D., PH.D.

Professor of Human Genetics; Pediatrics, and Medicine
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. II. HISTORY

The Growth and Development of Genetics
atMCV
J. IVES TOWNSEND, PH.D., Associate Professor of Human Genetics

Genetics was well established at the Medical
College of Virginia by the time I joined the faculty in
1960. At least one course in genetics was required of
students in the Schools of Medicine, Dentistry, Pharmacy, and Nursing. The Department of Biology and
Genetics, which was in the School of Pharmacy and
chaired by Dr. Roscoe D. Hughes, also had a modest
graduate program in genetics and two genetics research programs, one on facial growth in twins, supported by a grant from the National Institutes of
Hea lth , and the other on the genetics of drosophila,
supported by the National Science Foundation.
In 1938, Dean Wortley Fuller Rudd of the
School of Pharmacy had hired Dr. Hughes to teach
general biology and comparative anatomy to the undergradua te pharmacy students. Dr. Hughes, a graduate of the US Naval Academy at Annapolis, had
just received his Ph. D . degree at Columbia University for cytogenetic studies on drosophila under the
tutelage of the distinguished cytologist, Franz Schrader; this was the same department in which the Nobel
Prize winner, Thomas Hunt Morgan, had begun his
pioneer work three decades earlier. Dr. Hughes had
the added advantages of direct association with Morgan and other great geneticists, including Leslie C.
Dunn and Calvin B. Bridges.
It is hardly surprising then that after his arrival
at MCV, Dr. Hughes wanted to introduce genetics
into the various professional curricula; however, except for simple Mendelian principles taught in the
This is paper #42 from the D epartment of Human Genetics of
the Medical College of Virginia.
Correspondence a nd reprint requests to Dr. J. Ives Townsend ,
Box 33, Medical Co llege of Virginia, Richmond, Virginia 23298.
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general biology course to pharmacy and nursing students, no opportunities arose until sometime after
World War II. By the late 1940s, the controversy over
the dangers of fallout from atomic bomb tests had
made the general public as well as clinicians aware
that genes affect the health of everyone a nd undoubtedly helped to create the opportunities that Dr.
Hughes had been looking for. Dr. Hughes 1 reported,
"Beginning in 1949, three or four lectures in genetics
were given to second-year dental students. The number gradually increased to eleven. In 1954, the course
was placed on a formal basis and from then on carried academic credit. Also, during this period occasional lectures were given on special topics to other
classes." This was, I believe, the first required genetics course in a dental curriculum anywhere.
Medical Genetics first appeared as a required
eleven-hour course in the MCV Bulletin, Winter,
1951 . While this was probably not the first required
genetics course in a medical curriculum, it was certainly among the first. Genetics remains a required
subject in the Schools of Medicine and Dentistry.
In 1953, Marion Waller, now Professor of Medicine at MCV, received the first graduate degree to be
earned in the Department of Biology. As has been
true of a ll research conducted in that department or
in one of its successors, her research was in genetics.
The next year, Dr. Bertram L. Hanna, a mathematical geneticist, joined the faculty of the department, doubling the number of faculty a bove the ra nk
of Instructor . Expansion of genetics courses in the
various professional schools led to the department
being renamed, Depa rtment of Biology and Genetics.
(Although this name appeared in the MCV Bulletin
for years beginning in April, 1956, Dr. Hughes once
MCV QUARTERLY 13(4): 138- 139, 1977
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told me that he amended the name himself and soon
everyone followed his lead without there ever having
been any official approval.)
In 1963, the department was offering nine
courses in its graduate program. By the fall of 1965,
there were seven genetics graduate students in residence; this number had risen to nine by the fall of
1972.
After MCV and Richmond Professional Institute merged to form Virginia Commonwealth University in 1968, and Dr. Hugh es retired in I 970, the
responsibility for teaching anatomy to the pharmacy
students was assigned to the Department of Anatomy; the Department of Biology and Genetics had
become, in effect, a department of genetics. The
newly appointed president of VCU, Dr. Warren W.
Brandt, decided, however, that four faculty members
were too few to constitute a "viable" department; so
the department's name was changed to Program in
Human Genetics, and the program was transferred to
the School of Basic Sciences and in 1974, moved from
McGuire Hall to the eleventh floor of Sanger Hall.
Although the genetics faculty has ceased having
any role in the education of undergraduate pharmacy
students, it has maintained responsibility for lectures
on the genetics of special pathological conditions discussed in Nursing Health Science. Lectures on appropriate genetics topics are still given in the dietetic
intern program and to students in blood banking.
Because a study 2 made by the Virginia State
Council of Higher Education in 197 I considered the
number of graduate degrees earned in the Program in
Human Genetics at MCV to be too few, the VCU
administration approved a plan to expand the program at the earliest opportunity. Implementation began when Dr. Walter E. Nance was recruited as
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Chairman in September 1975. There shortly followed
the third name change to succeed Department of
Biology-Department of Human Genetics.
Since 1975, rapport with clinical departments
has been strengthened, especially with the Department of Pediatrics, which had been closely involved
with the Program in Human Genetics, and with the
Department of Obstetrics and Gynecology, which
had not. Faculty joint appointments have been made
to several clinicians who have especial interest in
genetics and are involved in teaching clinical genetics
or in sponsoring graduate students in genetics.
In addition, both the space occupied by Human
Genetics in Sanger Hall and the number of graduate
students in the Department have doubled; the number of nonprofessional employees in the Department
has grown more than sixfold; the amount of external
grant support awarded to the Department's faculty
has increased to more than $600,000 per year; and the
Department has received a predoctoral training grant
from the National Institutes of Health which will
provide stipends for six students. During the coming
year two additional faculty members will be recruited, increasing to six the number with primary
appointments in Human Genetics. After the benign
neglect of genetics, these developments promise to
fulfill the dream of having an outstanding human
genetics center at MCV, a dream long held by MCV's
first geneticist, Dr. Hughes.
REFERENCES
I. HUGHES RD: Genetics in the dental curriculum, in Witkop CJ
Jr (ed.): Genetics and Dental Health. New York, McGraw-Hill
Book company, 1962, pp 281-284.
2. State Council of Higher Education for Virginia: A Study of
Graduate Degree Productivity, June 1, 1971.

Ill. PRENATAL DIAGNOSIS PROGRAM

Indications for Antenatal Genetic Diagnosis
FAY REDWINE, M.D., Assistant Professor of Obstetrics and Gynecology and of Human Genetics
ROBERT. E. PETR ES, M .D., Associate Professor of Obstetrics and Gynecology
The diagnosis of chromosomal and metabolic
abnorm alities by mid-trimester amniocentesis is now
an established part of antenatal care. Jacobson published the first use of this technique in 1967,1 followed
in 1968 by Nadler. 2 By 1974, over 3,000 pregnancies
had been studied permitting the prenatal diagnosis of
a wide variety of chromosomal anomalies and more
than 60 different inborn errors of metabolism during
the second trimester of pregnancy at a time when
termination of the pregnancy can be safely performed
if an abnormality is detected . During this period, the
National Institute of Child Health and Human Development established a Nation al Registry for amniocentesis in an attempt to document the safety and
accuracy of this technique. Its report was published
in 1975 and dealt with a comparison of 1,040 pregnancies studied by mid-trimester amniocentesis and
992 matched control pregnancies.3 The conclusions
from the study were that mid-trimester amniocentesis
was a safe procedure when performed by a qualified
physici an and that the accuracy rate of antenatal
genetic diagnosis was 99.4%. Since 1975, the use of
this procedure has become almost routine in pregnancies at risk for identifiable genetic abnormalities
because of maternal age or family history. It should
be emphasized that in the vast majority of cases prenatal genetic diagnosis is a life-saving procedure.
Many women who are at high risk would not choose
to continue their pregnancy unless they could be assured that there is no detectable fetal abnormality . In

This is pa per #41 from the Depa rtment of Human Gen etics of
th e M edica l C ollege o f Virginia and was supported in part by a
Developmental Disabilities Grant from the Depa rtment of Mental
Health and Menta l Ret a rd ation of the Commonwealth of Virgini a.
C orrespondence a nd reprint requests to Dr. Fay Redwine,
Box 34, Medical College of Virginia , Richmond, Virginia 23298.
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the series of 1,040 amniocentesis procedures mentioned above, only 34 abnorm alities were detected ; of
these, 27 women elected to terminate their pregnancy.
In addition, 11 male fetuses were identified among
the 21 at risk for X-linked disorders and 8 of these 11
women elected to terminate their pregnancies.
Because the number of qualified laboratories is
limited, the cases which can be studied must be restricted to certain high-risk categories. The largest
group of pregnant women at increased risk of producing an abnormal child are patients over 35 years
of age. It is well established th at as the mother ages ,
the incidence of nondisjunction in her gametes increases. Table I shows the relation between the incidence of trisomy 21 and maternal age. Another
indicator of the effect of maternal age is that while
only 13% of pregnancies occur in mothers over 35
years old , these pregnancies produce 51 % of all cases
of Down syndrome. Recent studies employing normal chromosomal markers 4 have clearly shown that
the extra chromosome in this syndrome is not invaria bly maternal in origin. If only those cases in
which the nondisjunction occurred in the mother
were considered, it seems likely that a more striking
relationship to the maternal age would be observed .
Age 35 is considered by many to be the maternal age
at which the risk is sufficiently great to recommend
amniocentesis, but this figure is obviously somewhat
arbitrary .
The second largest group of patients for whom
antenatal diagnosis is recommended are women who
have already had a child with trisomy 21 . The risk of
producing another mongoloid child in this group is
I% to 2%. Needless to say, these mothers are also
extremely anxious about a recurrence, and in most
cases the results of the cytogenetic analysis serve to
all ay their fears.
MCV QUART E RLY 13(4): 140-143, 1977
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TABLE I
Relation of Maternal Age and Chromosome Abnormalities
Distribution
of mothers
of children Risk of chromosome
Di stribution
with
abnormality by
of total chromosome
age group
sample abnormality
Maternal
(%)
(%)
Age
N
Percentage

10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49

0.4
11.0
34.4
32.0
14.3
6.2
1.4
.07

0
5.3
42.4
21.2
5.3
21.2
5.3
0

0/ 19
1/ 490
8/ 1531
4/ 1423
1/635
4/ 277
1/ 62
0/ 3

0.20
0.52
0.28
0.16
1.44
1.61

Distribution of materna l ages. N = number of abnormalities
divided by number in age group.

A small group of patients at considerable risk for
chromosomally abnormal children are families in
which one of the parents carries a chromosomal
translocation . In these cases, the risk varies depending on the translocation . For example, in the case of a
t(2 l ;21) carrier, the risk of bearing a mongoloid child
is 100%; while in the case of the more common DI G
translocation t( 15;2 l ), the risk of producing a child
with translocation Down syndrome varies from
about 10% to 30% depending upon whether the father
or the mother is the translocation carrier. This translocation group is responsible for "familial mongolism" and is fortunately quite rare. Of all mongoloid children, 2% to 3% are of the translocation type;
of these, only about half are familial and the remainder are de novo translocations.
Approximately 150 genetic diseases have been
recognized which show an X-linked pattern of transmission, and many such as the X-linked hemophilias,
Duchenne-type muscular dystrophy, and agammaglobulinemia are associated with serious or even
lethal disease . X-linked disorders only affect male
offspring, although carrier females may occasionally
show mild symptoms. Specific intrauterine diagnosis
is not yet possible for most X-linked traits; however,
since it is possible to diagnose the sex of the child in
utero, carrier females can avoid giving birth to additional affected males if they are willing to carry only
female infants to term . Some couples find this an
acceptable method of completing their families with-
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out the fear of a recurrent abnormality; others do
not. In any case the decision about whether or not to
use this approach is made by the parents themselves.
The dilemma of terminating potentially normal pregnancies would be solved if specific tests were available
to diagnose each X-linked disease. Currently, this is
possible only for a relatively few X-linked diseases in
which the specific enzymatic defect has been identified . These conditions include Hunter syndrome, the
Lesch-Nyhan syndrome, and Fabry disease. In addition, approximately 40 rare autosomal recession
traits are known in which the enzyme defect can be
detected with varying reliabilities in fibroblasts.
The last category of patients at risk for specific
fetal abnormalities are those who have had a previous
child with a neural tube defect (anencephaly, enccphalocele, meningomyelocele, and spin a bifida ). As a
group, the recurrence rate for any of these disorders
is about 5%. 5 These abnormalities are not chromosoma l defects, therefore, the fetal karyotype is not
useful. However, it has been well proven that the level
of alpha-fetoprotein in the amniotic fluid at 16 to 18
weeks gestation correlates with these defects; a high
level of alpha-fetoprotein (greater than 5 standard
deviations above normal) is diagnostic of an open
neural tube defect. Amniography, fetoscopy, and ultrasound can also be utilized to document these abnormalities.
In summary, the general indications for amniocentesis for prenatal diagnosis are as follows:
I. Maternal age greater than 35 years at time of
conception.
2. History of a previous child with Down syndrome or any other trisomy.
3. Documented chromosomal translocation in
either parent.
4. Previous child with a serious inherited Xlinked disease or an autosomal genetic disease
that can be detected prenatally.
5. Previous child with a midline neurologic defect.
Table 2 is a summary of the indications for amniocentesis performed at MCV since 1973.
Patients who have been counseled and have a
definite indication for prenatal genetic diagnosis, and
who have given their informed consent, are first
scheduled for an ultrasound examination. Thi s noninvasive scanning procedure can locate the placenta,
identify the best area for the amniocentesis, and rule
out twin gestations. It also accurately measures the
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TABLE 2

Indications for Prenatal Diagmisis at MCV
(9-1-73 to 7-1-77)
28
77
65
8
I

IO
22
I
2

I
2

Previous trisom y 21
Maternal age 40 yr o r greater
Maternal age 35 yr to 39 yr
Close reiati ve with trisomy 21
Previous child with hemophili a A
Previous spi na bifida + cleft palate
Previous spina bifida or hydrocephalus or meningocele
Previous anencep halic
Previous Potter syndrome
Anophthalmia
Previo us G I G translocation carrier
Previous DI G translocation carrier
Elevated maternal creatine phosphokinase
Previous child with Sandhoff disease
Four previous spontaneous abo rtions
Previous trisomy 18
Previous trisomy 13
Previo4s XX / XO mosaics
Three previous "retarded" children
Previous child with "multiple defects"

fetal head to document fetal age. After the ultrasound
procedure, the patient's abdomen is prepared and
under sterile conditions the amniocentesis is performed by an experienced obstetrician. The amniocentesis procedure involves the introduction of a
small bore needle through the mother's abdominal
wall into the uterus and amniotic cavity under local
anesthesia. The ultrasound examination ilids in selecting the proper placement of the needle to avoid
the b<1by and to locate the amniotic fluid . Twenty
milliliters of fluid are withdrawn and the needle removed . Most patients have no ill effects from the
procedure and can go home shortly after it is performed. The optimum time to obtain the amniotic
fluid is from 15 to 16 weeks gestation .
Preliminary results are usually available within
three weeks of the procedure and the final report is
issued one to two weeks later.
Since most of the patients have a rate of below
5% of bearing an affected child, the results are usually
that the fetus has a normal chromosome complement. This greatly relieves the parents' anxiety and
allows them to have a happy prenatal course and
enjoy ;i normal baby. If, however, a mongoloid fetus
or a fetus with anencephaly is diagnosed, the parents
are counseled and pregnancy termination suggested.
This decision is left to the parents once the facts are
presented to them, and even for those parents who

TABLE 3
Medical College of Virginia Results of Antenatal Diagnosis
(9-1-73 to 7-1-77)
R ESULTS
92XXXX
46XY
46XX
45XY-D-G + DI G
45XO
47XY + G
47XX+G
47XXX
Normal alpha-fetoprotein
Abnormal alpha-fetoprotein

NUMBER

104
84
I
I

2

21
I

felt before the study that there would be no question
of terminating the pregnancy if the fetus were abnormal, the decision is a difficult one.
As of July I, 1977, at MCV, three patients, of
216 studied, have been diagnosed with trisomy 21 in
utero. All three patients underwent therapeutic abortion . In addition, the diagnosis of a fetus with Turner
syndrome (45XO) was made and the parents elected
to continue the pregnancy since the abnormality detected was not life-threatening. Table 3 summarizes
the results of the antenatal testing at MCV.
The future of antenatal genetic diagnosis is an
exciting one. Recent advances include the application
of chromosomal banding te~hniques to identify
subtle abnormalities and rearrangements; ultrasonography, using high resolution gray scale equipment
to permit delineation of fetal soft tissue and skeletal
anomalies; and fetoscopy , using a small fiberoptic
instrument to view the fetus directly and observe its
development. With the~e ad~ances in technology, it
should be possible to enable even more women at
high risk for genetically diseased offspring to bear
healthy children.
Table I is adapted from Science (169:495-497, 1970).
REFERENCES
I . JACOBSON CB, BARTER RH: Intrauterine diagnosi s and management of genetic defects. Am. J Obstet Gynecol 99:796-807, 1967.
2. NADLER HL: Antenatal detection of hereditary disorders. Pediatrics 42:9 12-918 , j~(i8.
3. The Safety and Accuracy of Midtrimester Amniocentesis for
Prenatal Diagnosis. National Registry for Amniocentesis Study
Group, National Institute of Child Health and Human Development, 1975 .
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4. MAGERUS RE, OVERTON KM , CHAMBERLIN J, ET AL: Parental
origin of the extra chromosome in Down 's syndrome. Hum
Genet 37:3-16, 1977.

143

5. MILUNSKY A, ALPERT E: The value of alpha-fetoprotein in the
prenatal diagnosis of neural tube defects. J. Pediatr 84:889-893,
1974.

Recent Advances 1n Cytogenetic Technology
for Antenatal Genetic Testing
JUDITH A. BROWN, PH.D., ANNA CARR, ELIZABETH S. COOPER, AND
DEBORAH W. HERITAGE, Cytogenetic Laboratory, Department of Human Genetics

The examination of human chromosomes has
been a part of the physician' s laboratory armamentarium since the correct diploid number of human
chromosomes was established' and a method was
developed 2 for the in vitro growth of peripheral blood
leukocytes to yield metaphase chromosomes. The
discovery3 that on ultraviolet microscopy (UV),
metaphase chromosomes stained with ftuorochrome
dyes displayed a characteristic pattern of bright and
dull bands unique for a given pair of homologous
chromosomes, was a major technological breakthrough in huma n cytogenetics; for the first time,
every chromosome in the karyotype could be unequivocally identified . Although the short storage life
of ftuorochrome-stained chromosomes and the costs
of UV microscopy have limited the usability of fluorescence banding, the introduction of one discriminating procedure quickly led to the development of an
array of similar banding techniques for conventional
This is paper #40 from the Department of Human Genetics of
the Medical College of Virginia and was supported in part by a
Developmental Disabilities Grant from the Department of Mental
Hea lth and Mental Retardation of the Commonwealth of Virginia.
Correspondence and reprint requests to Judith A. Brown, Box
33, Medical College of Virginia, Richmond, Virginia 23298.
MCV QUARTERLY 13(4): 143-146, 1977

microscopy that yield comparable information. Some
of these technical procedures depend on enzyme and/
or heat denaturation of the chromosomes, resultiri~
in the characteristic banding patterns seen by the
trypsirt-Giemsa method, 4 the 5M urea method, 5 and
the acid-saline-Giemsa technique.6 A typical human
karyotype prepa red from metaphase chromosomes
treated with trypsin, stained with Giemsa, and photographed with brightfield photomicrographic techniques is shown in Figure I. Careful examination of
this karyotype reveals that each chromosome in the
homologous pair has an array of dark and light
bands identical with those of its homolog and that
each homologous pair, autosomes number I to number 22, has a characteristic, easily identifiable ba nding pattern.
In order to establish a standardized nomenclature to describe the chromosomes and chromosome
regions, as revealed by the banding techniques, a
committee of international experts in human cytogenetics met in Paris, France, in 1971. 7 The committee retained the previously established designation
of the short arm of the chromosome as "p" and the
long arm as "q" and agreed to divide the chromosome arms into a number of regions according to the
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Fig I-Normal female karyotype. Chromosomes were treated
with trypsin and stained with Giemsa. (Chromosome magnification, X4000.)

position of the centromere and the banding characteristics of the arm. For example, the long arm of
chromosome 7 (7q) (Fig I) consists of three regions
(I to 3) which are more or less delimited by the two
major dark bands and the lighter staining terminal
band. If a patient has a deletion in the long arm of
this chromosome beginning with the second dark
band from the centromere and including all the rest
of the long arm to its terminus (ter), the designation
would be del (7) (pter _, q2 l: ). Such a detailed description of the karyotype abnormality makes it possible to associate the physical abnormalities of a
given patient with a given chromosome abnormality
and thus establish the phenotype-karyotype correlations which are extremely important in the diagnosis
of the so-called chromosome syndromes.
Major indications for a karyotype examination
are the evaluation of a newborn with multiple congenital abnormalities, psychomotor retardation of
unknown etiology, or ambiguous genitalia; of an
adolescent with short stature and / or delayed puberty; of selected cancers such as chronic myelogenous
leukemia, retinoblastoma, and cancer of the bladder;
of patients with a history of multiple spontaneous
abortions or infertility; and of high-risk pregnancies
by antenatal genetic testing. Whenever one of the
above conditions occurs, aberrations in the chromo-

somes are a frequent finding . Recently completed
newborn surveys show that approximately I% of all
live-born children have a significant chromosome abnormality which leads to severe physical and mental
handicap. Chromosome studies of fetal tissues obtained from early spontaneous abortions clearly indicate that karyotype abnormalities are a contributing factor in more than 50% of cases .
The utilization of chromosome banding procedures in antenatal genetic testing has resulted in a
more accurate description of the fetal karyotype and
increased diagnostic capabilities. Heretofore, it was
possible only to document the existence of an abnormal number of chromosomes-a condition known as
aneuploidy-as found in Down syndrome, 0-trisomy, or E-trisomy, while major or minor structural
aberrations went undetected. At the same time,
greater expertise in the interpretation of the karyotype result is demanded, and frequently chromosome studies of the parents are essential for a correct
interpretation of the cytogenetic findings in the fetus
(Figs 2 through 4 ). The fetal karyotype in Figure 2
shows two chromosomes, chromosome 15 and
chromosome 21 , with a considerable amount of extra
chromatin in the short arm (indicated by arrows),
which can easily be construed as an abnormality.
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Examination of the parental karyotypes shows that
the mother (Fig 3) possesses the variant chromosome
21 and_the father (Fig 4) the variant chromosome 15.
These chromosomal differences, referred to as normal or polymorphic variants, are often seen in humans with a frequency that depends on the particular
chromosome; they are compatible with clinically normal phenotypes . The fetal karyotype in Figure 2,
therefore, is normal. Another kind of polymorphism
which can confuse the correct interpretation of a fetal
karyotype is centromeric heterochromatin (Fig 5 ). In
this case, one of the homologs of chromosome pairs
I, 9, and 16 is larger than its normal .homolog-that
is, heteromorphic-and the size difference can be attributed to a larger amount of inactive chromatinheterochromatin as revealed by an alk ali treatment of
the chromosomes, developed by Arrighi and Hsu. 8
These so-called C-band polymorphisms are encountered in the normal population with a frequency that,
depending on the chromosome, shows characteristic
racial distributions .
The in vitro culture of amniotic fluid cells for
antenatal genetic testing can be complicated in approximately I% of cases by contamination of the
culture with cells of maternal origin. Here, whereas
fetal cells can be readily discriminated if the fetus is
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or deletion recognizable by current technology can
result in major phenotypic abnormalities. For example, Figure 6 shows an array of pairs of chromosome 4 ascertained in a child referred to MCV because of severe multiple congenital anomalies noted
at birth. Briefly, this infant female had microcephaly
with a midline occipital scalp defect, mild hypotelorism, low-set, simple ears with preauricular pits, bilateral cleft lip and palate, and a bulbous nasal root. She
also had mild flexion deformities of both thumbs and
hypoplastic nails, as well as congenital heart disease
and a shallow pilonidal dimple. Cytogenetic evaluation revealed a modal number of 46 chromosomes,
but as this figure demonstrates, one of the chromosomes 4 consistently showed a lesser amount of short
arm material than the homolog, and banding analysis
revealed a terminal deletion in the short arm:
46,XXdel(4)(pl5 or pl6).
Unfortunately, in the above case, the cytogenetic
diagnosis was made postnatally. Further refinements
of our current technology will soon permit such minor chromosome anomalies to be detected prenatally,
and as more patients elect antenatal genetic testing
and as banding and optical technology are improved,
karyotype analysis of the fetus will become an even
more precise diagnostic tool.
REFERENCES

Fig 6-Chromosomes 4 from four different cells of newborn described in text. Arrows indicate the location of the small deletion.
(Chromosome magnification, X4000.)

male, a knowledge and use of chromosome polymorphisms is used when the fetus is female to rule out
the presence of maternal cells and assure that the
karyotype is fetal. This technical difficulty can further
be circumvented by establishing two or more cultures
from the amniotic fluid sample and subculturing the
cells at least once prior to karyotype evaluation. Assaying duplicate cultures also increases the accuracy
of the test where chromosome mosaicism may result
in an abnormal offspring.
The application of chromosome banding techniques has vastly increased the precision with which
structural rearrangements can be characterized. This
in turn has contributed to the mapping of specific
genes to specific regions and bands of the chromosome and has led to the recognition of a growing
number of syndromes resulting from small duplications, deficiencies, or rearrangements of the
chromosome material. Even the smallest duplication
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IV. CLINICAL PROGRAM

The Genetic Counseling Program at MCV
PHYLLIS WINTER , Clinic Coordinator, Department of Human Genetics
PETER MAM UN ES, M .D ., Professor of Pediatrics and of Human Genetics
WALTER E. NANCE, M.D., PH.D., Professor of Human Genetics, Pediatrics, and Medicine

The Genetic Counseling Clinic at the Medical
College of Virginia, established by Ors. Peter Mamunes and R. B. Young in 1973 , has been supported
since its inception by a clinical service grant from the
National Foundation-March of Dimes; it is one of
83 genetic counseling programs in the United States
and one of three in Virginia that receive support from
the Foundation. The Clinic provides counseling and
diagnostic services for a variety of genetic diseases
and is the focus of clinical teaching and research
activities of the Department of Hum an Genetics . The
Clinic is staffed by members of the Departments of
Human Genetics, Obstetrics, and Pediatrics, as well
as consultants from many other clinical disciplines .
Following referrals, patients are sent a questionnaire to initiate the collection of relevant medical and
genetic data; the patient is then scheduled for a Clinic
appointment. At the time of the Clinic visit, the graduate student interviews the patient and documents
sufficient family history information to perm it the
construction of a pedigree. Following review of the
collected data and physical examination of the patient by the staff physician , the patient and family are
invited to continue the counseling session in a room
equipped with a microphone and a two-way mirror.
In this setting, students, house officers, and staff
members can participate in the counseling session in
an unobtrusive manner, and discuss it later. About

This is paper #33 from the Depa rtment of Hum a n Genetics of
the Medica l College of Virginia and was supported in part by
Grant C-178 from the Nati o nal Found ation-March of Dimes.
Correspondence and reprint requests to Phyllis Winter, Box
33, Medical College of Virgini a, Richmond , Virginia 23298 .
MCV QUARTERLY 13(4): 147-148, 1977

90% of the patients and families are willing to participate in this educational program ; those who object
are counseled privately .
After a year's experience in the Genetic Counseling Clinic, graduate assistants are assigned to specialty areas such as hemophilia, cystic fibrosis, and
endocrine clinics, where they collect family history
data in selected cases , under the supervision of the
Clinic director and augment the genetic counseling
the families have previously received. Although virtually all patients seen by the graduate assistant in
these clinics have a clearly defined Mendelian disease,
many may not have received adequate genetic counseling in the past.
Since its beginning in 1973, the Clinical Genetics
Program has evaluated or counseled 698 individuals
(Table); of these, 33.7% were diagnosed as having
a simple inherited Mendelian trait and 45 .6% a
recognizable chromosomal disorder. Twenty-one
dominantly inherited traits were diagnosed including achondroplasia, neurofibromatosis, Huntington
chorea, Marfan syndrome, retinitis pigmentosa, hypochondroplasia, Noonan syndrome, aniridia, limbgirdle dystrophy, Treacher-Collins syndrome, and
tuberous sclerosis; 28 recessive traits were diagnosed including cystic fibrosis , alpha-1-antitrypsin
deficiency, recessive deafness, Tay-Sachs disease,
Werdnig-Hoffman disease, galactosemia, phenylketonuria, Gaucher disease, Usher syndrome, and
maple syrup urine disease. X-linked traits seen in the
clinic included Duchenne muscular dystrophy, hemophilia, Norrie disease, anophthalmia and CharcotMarie-Tooth disease. Most of the cases seen with
chromosome anomalies had Down syndrome, but the
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Summary of Genetic Clinic Population: 1973-1977
Tota l

Year

C lassification
Dominant
traits
Recessive
traits
Sex-linked
traits
Chrom osomal
disorders
Multi factorial
traits
Other
conditions
TOTAL

1973-75

Num- Percent
1977
ber of total
1976 Jan-June

16

55

40

111

12.2

46

54

61

161

17.8

16

II

7

34

3.7

106

258

49

413

45.6

16

24

10

50

5.5

41

55

42

138

15.2

241

457

209

907

100.0

defects, diabetes, uncomplicated cleft lips and/ or palate, clubfeet, seizures, and certain patients with familial mental retardation that could not be otherwise
classified. Patients falling into the other categories
included individuals with multiple malformations or
repeated abortions with normal chromosomes and no
other definite causes, or patients with psychomotor
retardation of unknown or environmental etiology.
During the year 1976 (Figure), patients came
from all parts of the state either to the Genetic Counseling and Amniocentesis Clinics or for diagnostic
ka ryotypic analysis. This pattern of referrals is
largely a result of the central location of the Clinic in
a large urban area.
Referrals to Genettc Coooseing Program

sample included pa tients with D and E trisomy, the
cri du chat syndrome, Turner syndrome, Klinefelter
syndrome, the 4p-syndrome, and a variety of structural rearrangements.
Patie.nts classified as having multifactorial diseases included individuals with midline neurologic

from Virginia's Health C•e Districts, 1976

Figure-Pattern of referrals to Genetic Counseling Program
from Virginia's health care district, 1976.

Population Screening for Genetic Disease
PETER MAMUNES, M .D., Professor of Pediatrics and of Human Genetics

Recent advances in genetics and laboratory techniques have raised difficult issues for both the medical
This is paper #38 from the Department o f Human Genetics of
the Medical College of Virginia .
Correspondence and reprint requests to Dr. Peter Mamunes,
Box 187, Medical College of Virginia, Richmond, Virginia 23298.
M C V QUARTERLY 13(4): 148-151, 1977

and lay communities. The desirability of initiating
population screening progr.ams is an example of one
such issue that has engendered considerable confusion concerning its intent-so much so that the
National Academy of Sciences recently reviewed this
subject and in 1975 published a book entitled, Genetic Screening-Programs, Principles and Research. 1

MAMUNES: SCREENING FOR GENETIC DISEASE
This presentation will describe the four major forms
of population screening for genetic disease and, from
the Virginia experience with some of them, demonstrate their strengths and shortcomings.
Most readers are already aware of programs to
screen for disorders such as hypertension, diabetes,
cervical cancer, glaucoma, and other diseases. These
programs were established with the idea that they are
inexpensive, can be detected by a simple test, and that
effective treatment is available. The same principles
apply to the four major types of population screening
programs for genetic disorders.
I. Carrier detection. Almost all persons are believed to carry approximately four lethal or deleterious recessive genes; however, their existence is
usually never known unless the spouse has the same
gene, in which case there is a one-in-four chance that
each child will inherit a "double dose" of the abnormal gene and develop the disorder. Fortunately, most
serious recessive diseases are rare, but there are twosickle cell disease and Tay-Sachs disease-which are
especially prevalent in specific subpopulations and
for which simple, reliable, and relatively inexpensive
carrier tests are available. Screening programs for
detection of heterozygotes (carriers) in both disorders
have existed in Virginia for at least five years. Elsewhere in this issue experience with the Medical College of Virginia Sickle Cell Program is described.
Tay-Sachs disease affects approximately 1 : 4,000
Ashkenazi Jewish births and is invariably lethal by
the fourth year because of the abnormal accumulation of a sphingolipid, ganglioside G M 2 , in the central nervous system. 2 Hexosaminidase A, the enzyme
which is necessary for the normal degradation of this
material, is inactive in these patients and is present in
only approximately 50% of normal activity in the
serum, white blood cells, and other tissues of carriers.
Women who are at risk to give birth to such children
can therefore be identified before pregnancy. If both
parents are carriers, an amniocentesis performed in
the second trimester can determine the enzyme status
of the fetus. If Tay-Sachs disease is found, the parents
then have the option to terminate the pregnancy to
avert the birth of an affected child.
Measurement of the serum enzyme level is not in
itself technically difficult, but so many factors affect
its activity (for example, pregnancy, cleanliness of
test tubes in which blood is collected, the time during
which the serum remains at room temperature before
freezing, storage temperature prior to testing, medications taken by patient) that it is not practical for
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the local physician to forward blood to the testing
laboratory from patients wishing their carrier status
determined. Although with special precautions and
arrangements, testing of remote patients can be done,
a more desirable procedure is to schedule periodic
mass community testing at various sites. These mobile screening clinics not only obviate the abovementioned difficulties but they offer a better opportunity to ensure that tested individuals have been properly informed regarding the purpose and possible
consequence of the testing. Because this concept of
carrier testing is a new one, the most difficult aspect
of such screening is to educate the public in the
importance of voluntary participation. Most people
will not have heard of the disease, and what is more
significant they find it difficult to believe that they
have a I: 30 chance of being carriers. A second obstacle to successful screening is the lack of funding for
such programs. After initial equipment cost outlay,
the cost for the Tay-Sachs test averages $7 .00 ±
$2.00, depending on the volume of tests, per individual. The MCV Tay-Sachs Screening Program, operative since 1972, was fortunate to obtain initial support from the Virginia State Department of Health
and local Jewish community organizations so that it
has been able to offer the test without a fixed charge
to tested persons.
As a result of Virginia screening, over 3,700 Jewish persons have been tested at sites in their own cities
of Richmond, Norfolk, Newport News, Roanoke,
and Fredericksburg; the metropolitan northern Virginia cities have used testing sites in southern Maryland and Washington, D.C., provided by Johns Hopkins Hospital. Over 100 carriers have been identified
and counseled, but surprisingly no carrier couple has
thus far been found. A full 25% of all adult Jewish
people in these cities have been tested. In almost all of
the more populous United States cities where testing
has been offered for several years, no more than 5%
to I 0% have appeared for this voluntary test. Clearly,
a significant educational effort is needed on two
fronts: to convince governmental agencies of the need
for appropriate funding for these programs and to
inform the public regarding the concept of disease
prevention by carrier detection. Support of these efforts is needed soon, for in the very near future carrier detection tests for other more common recessive
diseases, such as cystic fibrosis, promise to be available.
Phenylketonuria (PK U) carrier detection is a
second test that we currently provide, using a dis-
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criminant function, based on serum amino acid levels, that we have recently developed in our laboratory. In this case, since there is no ethnic group in
which the gene has a high incidence, we offer the test
to the collateral relatives of all new cases of PK U that
come to our attention.
2. Antenatal screening. There is a ~mall but
clearly definable group of pregnant women ,for whom
screening is indicated because of their substantially
increased risk of bearing a child with a genetic disorder. The Antenatal Testing Program, jointly administered by\ the Departments of Obstetrics and Gynecology, Human Genetics , and Pediatrics, is
discussed elsewhere in this issue.
3. Mass neonatal screening. The prototype in
this level of screening is the Guthrie test to detect
PK U, an assay performed on a dried blood spot
obtained in the first week of life. Virginia State law
established the program in 1966 and made it the joint
responsibility of the parent and / or the physician to
provide that the neonate be screened for this condition. Since that time, four to five children with PK U
per year (approximately 1: 16,000 births) have been
discovered and mental retardation averted by maintaining them on a phenylalanine-restricted diet for
the first six to seven years of life. The cost for early
screening and treatment is approximately one tenth
the cost of special education or institutionalization of
late-diagnosed, retarded PK U children .
With the demonstrated success of the PK U
screening program , many states and foreign countries
have established screening programs for other disorders using the same blood spots. The grafting of
these additional programs onto an already-existing
one and the availability of a machine to handle the
blood-spotted filter paper have minimized their cost.
The decision of which additional disorders to screen
should relate to the following major factors:
a)
b)
c)
d)

frequencyofthedisorder,
severity of the untreated disorder,
simplicity and sensitivity of the test, and
availability of treatment to ameliorate or prevent the disorder.

Under the above considerations, hypothyroidism (by
radioimmunoassay of thyroxine), galactosemia (by
bacterial inhibition assay) , and several aminoacidopathies including homocystinuria, maple syrup
urine disease (MSUD), and histidinemia (all also by
bacterial inhibition assay) qualify .3 Because of its
frequency ( 1 : 6,000) and ease of treatment, and the

severity of the mental retardation that ensues due to
delayed diagnosis, hypothyroidism warrants immediate development of screening programs .4 •5 Therefore,
a neonatal hypothyroid screening program in Virginia is planned for 1978. It is hoped that additional
programs for galactosemia and other aminoacidopathies will also be initiated soon.
The spectrum of metabolic disorders screened
can be considerably expanded if the urine of two- to
three-week old infants is.aiso tested by various simple
chromatographic and high-voltage electrophoretic
techniques . Such a program , using specimens collected on filter paper at home by the parent and
mailed to the central laboratory performing the
blood tests, has already been in effect for several
years in M assachusetts 6 and several other states. This
procedure also serves as a follow-up test to detect
neonates with false-negative blood results for the
previously mentioned aminoacidopathies, including
PKU .
Except for the PKU program, testing for other
disorders in Virginia and most other states is and will
be voluntary. An advisory committee of consumers,
experts in metabolic disease, geneticists, laboratory
personnel , clergy, and ethicists is clearly needed to
serve as an advisory body to determine the propriety
and mode of administration of these proliferating
programs.
4. Urine metabolic screening. While the total incidence of ihborn errors of metabolism is probably
no greater than 1: 5,000, these disorders are more
often seen in children with mental retardation, seizures, hepatosplenomegaly, recurrent or persistent
acidosis, failure to thrive, or unusual odor to urine or
sweat. Where the etiology of any of these conditions
is unclear, one of the inborn errors of metabolism
must be considered; therefore, a variety of simple
tests on a random urine specimen is recommended to
screen for over 30 such disorders of amino acid,
mucopolysaccharide, and carbohydrate metabolism. 7
At the pediatric metabolic laboratory the following
tests are routinely performed weekly on a 20 ml acidified random urine specimen received by mail: a)
ferric chloride and dinitrophenylhydrazine tests to
detect the alpha-keto acid excesses found in PKU,
tyrosinemia, MSUD, and histidinemia; b) silver nitroprusside test for homocystinuria; c) Benedict's
tablet for reducing substances; d) gross turbidity test
for mucopolysaccharidoses; e) isatin spot test for the
iminoaciduria of praline or hydroxyproline excess; f)
nitrosonaphthol test for tyrosinosis; and g) high-volt-
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age separation of all urinary amino acids to detect
any excesses. Although the yield of newly diagnosed
inborn errors by this screening program is small,
those few cases detect~d are important because they
may le;:id to a specific diagnosis that permits a prognosis, a recurrence risk for other family members,
and counseling about the possibility of treatment or
prenatal diagnosis for future pregnancies.
Clearly, genetic screening programs are an important component of the primary care physician's
efforts in preventive medicine. Participation in and
support of these programs is therefore strongly
urged.
REFERENCES
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The Virginia Sickle Cell Anemia Awareness
Program (VaSCAP): Education, Screening,
and Counseling
FLORENCE N. COOPER AND ROBERT B. SCOTT, M.D., Department of Medicine

In 1968, a program of screening for sickle trait
carriers was begun as part of the work of the Hematology Division, Department of j'vtedicine, at the
Medical College of Virginia. It was felt that sickle cell
Correspondence and reprint requests to Robert B. Scott,
M.D., Box 214, R.ichmond, Virginia 23298.
MCV QUARTERLY 13(4): 151-153, 1977

anemia was more of a public health problem than
was generally recognized, and in addition to institutipg screening and education programs, data were collected to document the relative neglect of the problem.
A survey of the Cjty of Richmond was conducted to ascertain the level of awareness among
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black adults of sickle cell anemia, a severe chronic
disease affecting one of every 500 black babies. The
results' showed that only 3 of every I 0 black adults
had ever heard of this disease, and of those who
recognized it, few understood the nature of the illness. Additional background information was collected which further showed the lack of professional
and public understanding of the importance of sickle
cell anemia as a public health problem. These data, 2 •3
which attracted widespread attention, showed that
sickle cell a nemia research received far less support
than other much Jess common chronic illnesses.
Public attention was also focused on sickle cell
anemia by publicity concerning a new "test tube" test
for sickling, and claims for therapeutic benefit from
intravenous urea solutions. The heightened interest in
sickle cell disease finally resulted in the Sickle Cell
Anemia Prevention Act of 1972, which included a
series of sickle cell research a nd treatment centers
plus screening, education , a nd counseling clinics
throughout the nation. At that time VaSCAP competed successfully for a contract under the national
program, and expanded from a small screening effort
to a larger, well-staffed clinic which could extend its
effects state-wide.
Although the ability to detect healthy carriers of
the recessive sickle trait had existed for years, no
widespread screening and genetic counseling had
taken place prior to these new programs. Another
factor which made mass screening economically feasible was the development of rapid, simple instruments for performing hemoglobi n electrophoresis. Electrophoresis has distinct adva ntages
over the cl assical sickle cell "prep" or the .newer test
tube tests since it can distinguish sickle trait from the
homozygous state, sickle cell anemia, and can also
detect numerous other hemoglobin variants.
The purpose of screening for abnormal hemoglobins is to give young people a n opportunity, not
previously a vaila ble, to know in advance of childbea ring whether they run the risk of having children
with sickle cell anemia. The frequen cy of sickle tr:tit is
about 8% of the black population, or I in every 12
blacks. The chance, then, that both potential parents
in a couple are trait carriers is I in 144; thus slightly
less than I% of black couples a re composed of two
trait carriers and are at risk for bearing children with
sickle cell anemia . The cha nce is 1 in 4 with each
pregnancy that a child will be born with this incurable
illness.
Screening should not be performed without ade-

quate prior education. To implement this principle,
VaSCAP has developed a number of audiovisual
programs and written materials suitable for a wide
variety of audiences. Included in these are the Sickle
Cell Anemia Fact Book, 4 a booklet for teachers,
nurses, and other professionals, and Our Sickle Cell
Story Fact Book, 5 for elementary and middle school
students. These, as well as brochures, posters, and
fact sheets are distributed through the Virginia State
Department of Health, to many areas of Virginia and
throughout the nation. Since its inception, VaSCAP
has provided educational sessions to over 200,000
individuals in groups of various sizes. It has also
reached many more through programs, spot announcements, and structured educational models for
specific target groups with the result that screening
for hemoglobin genes has become an acceptable procedure among the general population. At present
over 42,000 persons have been screened by hemoglobin electrophoresis and 3,951 have been found to
have hemoglobin variants.
The ultimate result of education and screening is
counseling those found to have sickle or other mutant
hemoglobin genes. Counseling is aimed at educating
the individual so that he or she can know the nature
of the sickle gene, understand what sickle cell anemia
is, understand the probabilities of transmitting the
genes, and then be able to make informed decisions
about childbearing.There is a set of slides available
which has been developed by the VaSCAP staff.
These explain the probabilities of inheritance for each
specific hemoglobin variant. Individuals newly diagnosed with sickle cell anemia or one of its variants
have been referred to a famil y physician or to the
Hematology Clinic at MCV.
Approximately 8% of Virginia blacks have been
found to have sickle cell trait, and 2% carry hemoglobin C trait. About 0.3% have the gene for hereditary
persistence of feta l hemoglobin (HPFH), which is a
gene muta tion not associated with any disease. In
addition , a large number of less common mutant
hemoglobin genes have been recognized .
Though the alkaline electrophoresis test is the
primary method used for the detection of hemoglobin
genes, there are other methods which may be required in order to provide more conclusive results.
The laboratory of the VaSCAP clinic provides both
alk aline a nd acid or citrate agar electrophoresis. A2
mini-columns for hemoglobin A 2 qua ntitations are
very useful in detecting the Beta thalassemias; fetal
hemoglobin staining aids in determining the presence
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of HPFH. Family studies are necessary in certain
cases and the clinic has screened as many as four
generations in some families.
All of the services have been provided without
charge to the public or physicians for whom diagnostic testing has been performed. The emphasis has
been on testing persons in or approaching the childbearing age.
Education programs have been carried out in
most high schools and colleges in central Virginia and
the Tidewater area . Church groups and community
organizations regularly request programs, many of
which are provided in evenings or on weekends. An
important part of the educational effort has been to
provide workshops to train public health nurses in
genetic counseling relating to hemoglobinopathies.
State legislstion has provided funds for nurses to be
designated as genetic counselors in all of the Health
Department clinics in the State. VaSCAP has also
worked closely with local health departments in providing consultations concerning diagnosis and counseling of individuals with unusual hemoglobin variants .
The number of individuals served by the VaSCAP clinic is a tangible measure of its performance,
but it does not reflect all of the benefits to the public
and health professionals. The tragic lack of public
awareness of the importance of sickle cell anemia that
characterized the beginnings of this program has disappeared. For health professionals, especially at
MCV, the subject of hemoglobinopathies has been
emphasized repeatedly, and the level of interest and
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understanding of the disease and its variants have
risen considerably. Of particular significance are the
improved diagnostic facilities provided by VaSCAP
clinics which have made it possible to stress the more
rigorous modern standard of diagnosis for hemoglobin disorders. 6 Perhaps most important to the field of
genetics generally has been the extensive practical
experience gained by the first mass screening efforts
for a heritable disease. The ease with which recessive
hemoglobin genes are detected made it the first such
program to be implemented; as additional gene tests
are developed, other genetic diseases will be the targets of similar programs.
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Genetics and Cancer
JOHN M. MUELLER, M.D. AND ROBERT B. DIASIO, M.D., Division of Medical Oncology

The existence of a relationship between cancer
and heredity has been recognized for years, but only
recently has emerging knowledge in this area enabled
physicians to detect and treat cancer earlier in affected individuals and to prevent its occurrence in
others.
The genetics of human cancer can be divided
into three categories: first, cancers inherited by direct
gene transmission ; second, familial disorders not
characterized by malignant disease themselves but
which predispose to an increased likelihood of developing cancer; third , cancers of one or more types
occurring with an increased incidence within a family
but with a mode of genetic transmission that may not
be clear.
A relatively small proportion of cancers are inherited as a result of direct single gene tra nsmission .
One example is retinoblastoma, a highly malignant
tumor of the eye which presents in early childhood,
and which occurs in two different forms. The less
common familial form of the disease is usually transmitted as a highly penetrant dominant trait, with affected individuals often having bilateral involvement
and a somewhat earlier age of onset. The more common form is characteristically sporadic, with affected
individuals having unilateral disease and a later age
of onset. 1 As more affected persons will now reach
adulthood and reproduce because of improved treatment, clarification of the mode of inheritance is
mandatory to allow proper genetic counseling.
Multiple endocrine adenomatosis type II or
Sipple syndrome consists of the association of medullary carcinoma of the thyroid, pheochromocytoma,
and parathyroid hyperplasia. This disorder appears
to be inherited as an autosomal dominant but with
incomplete penetrance. As with many inherited can-
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cers, there is a n increased incidence of bilateral organ
involvement. Clinically, the patient may present with
evidence of carcinoma in only one system; for example, medulla ry carcinoma of the thyroid may be
present without a palpable thyroid nodule. However,
appropriate testing may show occult disease in the
other organs. An elevated serum calcitonin level may
suggest a n occult cancer in predisposed individuals2 ;
therefore, diagnosis of any of the features of this
unusual syndrome should lead to careful exclusion of
the others, as well as to a search among close relatives
for additional, possibly presymptomatic, cases.
Familial polyposis coli is an a utosomal dominant disorder in which adenomatous polyps may be
so numerous that they actually carpet the entire colon
and rectum; Gardner syndrome is a distinct variant
that includes associated sebaceous cysts a nd osteomas of bone. Early recognition of these disorders is
critical since virtually I 00% of affected persons will
develop carcinoma of the colon by age 50 unless a
prophylactic colectomy is performed. 3 A number of
oncologists now recommend total colectomy as soon
as the disorder is discovered in childhood unless it is
possible to follow the affected child with regular sigmoidoscopies and barium enemas. The management
of these families can be extremely difficult since it is
essential both to stress the importance of regular
examination and to avoid contributing to a n obsessive cancer phobia.
Neurofibromatosis is a n a utosomal dominant
disorder characterized by cafe au lait spots and multiple neurofibromas. The neurofibromas show a sarcomatous degeneration in about 10% of patients, and
there is a n increased risk of gliomas of the brain or
optic nerve, meningiomas, acoustic neuromas, and
pheochromocytomas.
Xeroderma pigmentosa is a rare disorder manifested by sun sensitivity a nd the development of
freckles on sun-exposed areas which then become dry
and scaly. Basal cell and squamous cell carcinomas of
MCV QUARTERLY 13(4): 154-1 56, 1977
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the skin later develop , and even if they are arrested ,
affected individuals have an increased risk of mel anoma .1 Xeroderma pigmentosa is transmitted as an
autosomal recessive trait. The defect has been shown
to be a specific deficiency in one of the several enzymes normally required to repair ultraviolet radiation damage to the DNA of epidermal cells.4 When
the precipitating causes of the problem are appreciated, the physician can teach affected individuals to
protect themselves from the carcinogenic effects of
ultraviolet radiation without undue disruption of a
normal lifestyle. 5
Immune deficiency disorders are associated with
an increased incidence of cancer, particularly lymphoma. The prime examples are the recessively inherited syndromes such as X-linked agammaglobulinemia, ataxia tel a ngiectasia, and Wiskott-Aldrich
syndrome. Individually, each of these recessive syndromes is rare, and in the aggregate, affected homozygotes (or hemizygotes if the trait is X-linked) constitute only a small proportion of all patients who
develop cancer. However, there is increasing evidence
that heterozygous carriers of at least some of these
recessive genes may also be predisposed to cancer.
Carriers of rare recessive genes are, of course, much
more numerous in the general population than are
affected homozygotes ; in fact , the rarer the recessive
trait, the greater the relative frequency of heterozygous carriers in the population in comparison with
affected homozygotes . Therefore, a small effect of
cancer risk in heterozygotes could have much greater
public health significance than would a major effect
in homozygotes. Swift6 has provided convincing evidence that heterozygous carriers of the genes for
ataxia telangiectasia and Fanconi anemia have a
three- to fourfold increased risk of developing cancer;
he has estimated that at least 3% of all cancers arise in
individu als who are heterozygous for one or the other
of these two genes alone. At present, no laboratory
test is available to identify carriers.
Detecting an increased familial risk of cancer
and following the involved family members for evidence of developing neoplasia is an important activity for practicing physicians. The cancers may be
always of the same organ , that is, a site-specific tumor
may occur in familial aggregations, or they may be of
multiple varied organs. The Table lists the site-specific malignant neoplasms with possible familial occurrence.7
There is considerable heterogeneity in the genetics of certain cancers, especially breast cancer.
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Neoplasms with Possible Familial Occurrence

Breast
Co lon
St o mach
Prosta te
Endom etrium
Hodgkin di sease
Walden strom disease
Multiple myeloma
Leukemia

Lymph o ma
Hepa tocellular tumors
Testicular tumors
Neuroblastoma
Wilm s tumor
Burkitt lymphoma
Bronchogenic carcinoma
Ova ri a n ca rcinoma

Studies8 - 10 have helped elucidate some of the risk
factors . It is important to know whether the disease
has occurred in two or more female first-degree relatives, whether the disease was pre- or post-menopausal in onset, and whether it was bilateral. In
the premenopausal age group, the relative risk of
breast cancer among family members of an affected
individual is approximately three times that of controls, whereas in the postmenopausal age group, the
risk is only slightly greater than that of controls.
Relatives of women with bilateral disease have a fivefold risk compared to controls. The relatives of
women with premenopausal and bilateral disease
have a relative risk of developing breast cancer that is
almost nine times greater than that of controls, while
the relatives of patients with postmenopausal bilateral disease have a risk that is four times greater. The
risk to other family members also depends upon the
relationship of prior affected persons to the proband .
For example, if prior disease involved a proband's
mother, the proband's sisters will have a 30% incidence of cancer in the 20-to 29-year age group , a
risk 47 times greater than that of the general population . Clearly, these facts imply a genetic factor in
breast cancer which appears most consistent with
polygenic inheritance of a predisposition . Physician
recognition of and response to this inherited predisposition is important particularly in the high-risk
situation. In one such family , for example, bilateral
reduction mammoplasty with implantation of a subcutaneous prosthesis was recommended for a 19year-old girl whose two sisters, mother, and maternal
grandmother had had early onset of breast cancer. 11
The concept of "cancer families" has been
broadened to include kindreds displaying familial occurrence of diverse neoplasms even of dissimilar cell
types. 12 The cancer family has the following characteristics: I) an increased occurrence of adenocarcinoma primarily of colon and endometrium; 2) in-
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creased frequency of multiple primary malignant
neoplasms; 3) early age of onset of cancer relative to
the usual age of onset of that cancer in the general
population; 4) vertical transmission of cancer consistent with an autosomal dominant inheritance pattern.
One such family has been described in Virginia. 13
Environmental factors may also influence expression of the disease when there is a familial tendency to cancer. Studies by Tokuhata have confirmed
an increased incidence of cancer of the lung in relatives of patients with lung cancer, and his data suggest that the combined risk of cigarette smoking and
the familial host factor increase the liability of developing lung cancer in a synergistic rather than additive
manner. 1•
The interrelationships between heredity and environment in the occurrence of cancer are complex
and in many cases not completely characterized, but
certain facts are clear. Specific cancers can be inherited directly . Certain diseases that predispose to cancer are inherited, and specific cancers or specific tendencies to develop a variety of cancers are inherited
in families. Examples of each of these have been
discussed. The long-range challenge to physicians is
to recognize these situations and to study them thoroughly to further our understanding of the causes of
cancer. More immediately, however, the alert physician who takes a detailed family history can recognize
the increased risk of a particular malignancy and, by
careful examination, testing, advice, and follow-up,
can provide early treatment or even prevent the development of a potentially fatal malignancy. 11
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The Genetic and Somatic Effects of
Radiation: A Balance Between Benefits and
Risks
TIMOTHY MERZ, PH.D., Professor and Chairman, Division of Radiation Biology, and Professor, Department
of Human Genetics

The present clinical interest in mutagenic agents
in general and radiation in particular can be seen in
the current proliferation of popular articles a nd reports on the effect of mutagens and radiation on
biological systems. In spite of the continuing controversy over the effects of radiation from environmental sources, the most significant problem today is
the increasing x-ray exposure of individuals due to
increasing radiological diagnostic capability and the
expanding importance of radiographic procedures in
medical diagnosis .
Although man has survived radiation from natural sources during the course of his evolution, there is
a point at which the risk of exposure is greater than
any benefit that might be derived . The exposure dose
at which that risk occurs and how it is influenced by
the rate of exposure are being studied here at the
Medical College of Virginia and many other institutions. The human system is extraordinarily well
adapted to respond to the effects of radiation, chemical mutagens, and clastogens (compounds that break
DNA strands and chromosomes) through a repair
mechanism which more often tha n not returns things
to normal, but there is a limit to its capacity.
The genetic risk of radiation has been recognized
since 1927 when Muller reported that radiation induced mutations in fruit flies. 1 Auerbach, using nitrogen mustard during World War II, demonstrated that
chemicals could produce the same kinds of effects as
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radiation. 2 We are now becoming aware of the magnitude of the threat that chemical mutagens pose for
us in our environment. Since most chemical mutagens and clastogens produce effects similar to those
of radiation, have the same targets and a similar
dependence on dose and rate of exposure, and since
the consequences are much the same although the
mechanisms are quite different, I will concentrate
almost entirely on the effects of radiation .
Radiation does not cause new kinds of genetic
alterations but an increase in the frequency of alterations above the spontaneous level. Also there is no
obvious threshold dose of radiation; that is, there is
no dose below which there is no effect. Although no
threshold dose of radiation exposure has ever been
established, it is probably true that very low doses
impose a very low order of risk.
Human damage by radiation is divided into two
groups-germ cell (or presumptive germ cell) damage
and somatic cell damage. The primary events of alteration, be it the genome, induction of cancer, or death,
are always intracellular, the target being the genetic
material found in the nucleus and organized as
chromosomes. Thus, whatever the nature and extent
of damage done to humans, it is always first expressed by cells, then by tissues or organs, and finally
by the individual. The repair of altered DNA is accomplished by a group of enzymes that work with
great speed and accuracy. Most of the damage produced by a dose of radiation is repaired by the cell in
a very short time, but repair systems do not repair all
of the damage nor is all repair perfect. Many cells
will, for several reasons, survive and retain their function in the face of sustained genetic alterations. First,
cells maintain their synthetic function after exposure
157
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to doses of radiation that would kill human beings.
Enzyme systems and systems that synthesize protein
in general are not sensitive to large doses of radiation.
Second, the loss of genetic material is not necessarily
significant tp cells that have differentiated and use
only that information from the DNA that is pertinent
to their particular task. Third, the loss of genetic
material is most often the loss of one half of that
w.hich is supplied to the cells since it gets informational content from both parents. Fourth, some of
the 'genetic material is redundant and the loss of part
of it, while it may result in reduced capability, will
not necessarily result in death. Although cells can
function after exposure to radiation, a large number
of them will lose their ability to divide and replace old
cells. After doses of radiation of approximately 200
rads, many cells loose their reproductive integrity.
That loss is defined as reproductive death. Death ,
reproductive or actual, is only one significant result
of radiation . Changes in DNA base pairs, deletions
of materials, or chromosomal alterations often result
in mutations that are usually recessive and almo~t
always deleterious. When expressed, they result in the
loss of enzyme function and altered proteins. There is
a growing list of known enzyme-deficient disorders
and of stn.ictural protein abnormalities, sucb as abnormal hemoglobin variance, in man. Recessive mutations are not observed until they are present in both
maternal and paternal chromosomes and therefore
take at least two generations of breeding to be expressecj. In somatic cells recessive mutations will often go unnoticed; large losses or rearrangement of
material seen as chromosomal changes, chromosome
and cpromatid aberrations, exchanges of material between chromosomes, and large losses of pieces of
chromosomes usually cause more trouble and often
result in the death of the cell. In addition to causing
changes in the structural integrity of chromosomes,
radiation often results in changes of chromosome
number either by the addition or deletion of whole
chromosomes. Radiation-induced genetic damage
can be yxpressed in many ways, the simplest of which
go unnoticed. While death may be the most severe
result of a mutation, cell death is a minimal problem
for an organism whose tissues renew cell populations
continually; however, the death of many cells in critical stem cell populations of renewal tissues such as
the gut or the marrow will cause the death 'of the
individual. But these events do not occur as the result
of incidental exposure to : radiation.
The effects of low doses of radiation, chemical

'

'

mutagens or clastogenic agents can be listed for both
germ cells and somatic cells. The expressions of damage to germ cells are abortions, stillbirths, and congenital defects including all the known trisomies such
as Down syndrome. The fact that radiation can induce trisomic developmental anomalies in early
cleavage cells and germ cells is based both on theoretical considerations and on observations from published studies. The failure of chromosomes to disjoin
at mitosis or meiosis is a well known result of exposure to radiation and an event preliminary to the
production of trisomics. Germ cells or early cleavage
stage cells (em bryogenesis) that are missing chromosomes due to nondisjunction or have extra chromosomes for the same reason usually fare poorly and
often result in fetal death. The best studies oftrisomic
or polysomic conditions in man are those involving
the sex ~hromosomes . Extra sex chromosomes and
missing sex chromosomes often produce less deleterious consequences in fetal development than
changes in number of other chromosomes, but tbey
are never without later developmental cc:msequences.
The same developmental problems can be produced
by the insertion of pieces of chromosomes in other
chromospmes or the loss of pieces of chromosomes.
The e1(pression of somatic cell damage depends
on when the damage is d~ne . Damage done to fetal
cells wi)I often result in congenital defects and/ or
death. A minimal number of cells altered a't the time
when they are differentiating into a tissue or organ
system can produce a partially or totally defective
system . The earlier in development that exposure to
radiation occurs, the greater is the risk of congenital
defects. The risk of a particular system being defective is dependent on the stage of differentiation of
that system at the time of radiation exposure. Differentiating cells are by far the most sensitive cells in the
human system and they are apparently sensitive because their repair systems are not operating during
the time they are differentiating. Differentiating cells
are sixtyfold as sensitive as nondifferentiating cells.
It is also clear that cells undergoing the complex
process associated with organogenesis are particularly susceptible to genetic loss. Following organogenesis, the systems become considerably more resistant to radiation exposure or exposure to chemical
mutagens. The first two trimesters of fetal development have been considered by radiologists to be so
sensitive that most try to avoitj extensive radiological
investigations to women who may be pregnant. The
last trimester has been considered to be a safe period
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to the fetus, but current investigators have raised
some questions about the extent of fetal resistance io
radiation-induced damage even at that period of fetal
development. Probably the most extensive investigation of the effect of radiation on developing fetuses is
the Oxford Study directed by Stewart et al, 3 which for
all its excellence remains one of the most informative
but controversial studies on this subject. Although it
is a continuing investigation, the Oxford Study has
already provided data that indicates that obstetric
radiology as practiced some years ago in England
increased the prevalence of childhood cancers in general and more specificially the risk of leukemia. That
risk appears to be a function both of the number ofxray films taken while the fetus is in utero and the
stage of fetal development. Four other studies involving the effects of radiation on developing fetuses
also indicate that obstetric radiology even to third
trimester fetuses has probable deleterious effects. One
study by Meyer, Tonascia, and Merz 4 indicates that
there is a 15% increase in fertility in young females
exposed in utero and also a suggestion of differences
in growth, development, and behavior between exposed and control populations. Exposed women (in
utero) have completed fewer grades of school, have
poorer general health, more menstrual problems,
more of certain diseases and accidents, and are heavier for their height than the control population . Mullinex and her colleagues• working with rat fetuses
irradiated in utero have observed significant changes
in the behavioral activities of the rats that are exposed as compared with controls.
The major effect of very low doses of radiation
on adult somatic cells is the induction of tumors. One
of the difficulties of estimating the relationship between exposure to radiation and the induction of
tumors is the long latent period between the induction and the growth of the tumors. There is little
doubt, however, that tumors are induced by radiation
at low-dose levels. The most common cancer induced
appears to be leukemia possibly because no matter
what area of the body is irradiated, circulating peripheral cells are always exposed and exposed frequently. To understand. the risks involved in radiation exposure, one must remember that the dose of
radiation calculated to double the natural incidence
of diseases as a consequence of radiation exposure
(the doubling dose) is somewhere between 20 rem
and 200 rem . A rem is the absorbed dose in rads
multiplied by modifying factors such as tissue sensi-
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tivity and the penetrating or ionizing qualities of the
radiation in .question, with the test or biomedical
endpoint being measured. For most purposes one can
substitute the radiation absorbed dose (rad) for rem :
One rad equals an absorbed deposition of energy
equivalent to iOO erg/ gm of tissue. The maximum
permissible exposure to non-radiation workers is 0.5
rads per year. Radiation exposures associated with
typical diagnostic procedures such as chest films, gastroiritestinal series or an intravenous pyelogram
(IVP) are usually weli under the permissible dose, the
exception being the doses associated with the diagnosis and treatment of serious diseases. Most people
never are exposed to as much as 20 rads of ionizing
radiation in a lifetime. Even then the risk would be
low but riot insignificant since a 5 rem gonadal dose
per generation to a population would increase disease
due to mutation from 0.5% to 5.0% at equilibrium in
the population.
The questions regarding the advisability of exposure to radiation are almost always those of risk vs
benefit. Reasonable answers can be made only by
using care, judgment and flexibility . Mutagenic
agents are ubiquitous in the environment; they are
always dangerous, but in many instances the benefits
outweigh the risks associated with exposure. If a normal incidence of a disease or condition is I I I 00,000
individuals, doubling the risk only increases it to 2/
I00,000. That risk is not meaningless, but in many
instances it is low enough to negate concern when
reasonable benefit is to be derived from exposure.
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Juvenile Hyperlipemia
WILLIAM W. MILLER, M.D., Professor of Pediatrics

Asymptomatic hyperlipemia occurs in a significant number of American children. It is important to
recognize the condition during childhood because of
its role as a risk factor in the early onset of coronary
artery disease and because early dietary modification
may prevent changes leading to premature heart disease.
A predisposition to heart attack exists within
families, and now there is significant documentation
of familial aggregations of coronary atherosclerosis
as a concomitant of genetically determined risk factors such as hyperlipemia, hypertension, and diabetes
mellitus. 1 - 3 Of these three conditions, hyperlipemia,
which often displays a clearly genetic component, is
related most directly to the pathogenesis of atherosclerosis.
The following review will present the characteristics of juvenile hyperlipemia, note the known genetic influences, document its prevalence in children
in the United States, and present recommendations
for diagnosis and management.
Hyperlipemia is the manifestation of a variety of
biochemical abnormalities producing hypercholesterolemia and/or hypertriglyceridemia, both of which
are associated with an increased risk of coronary
artery disease in adults. Because hyperlipemia occurs
in early childhood and may lead to coronary atherosclerosis, the identification and treatment of children
with hyperlipemia should receive more attention than
it does at present. The definition of hyperlipemia is
indistinct; normal blood levels of cholesterol and triglycerides are defined statistically by measurements
in apparently healthy children. Although the levels
can vary geographically and may be influenced by
diet and other factors, "normal limits" have generally
been based on 90th percentile fiducial limits calcuCorrespondence and reprint requests to Dr. William W.
Miller, Box 291, Medical College of Virginia, Richmond, Virginia
23298.
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lated from relatively small samples (Table 1).4 A diagnosis of hyperlipemia is justified if lipid or lipoprotein concentrations, measured after a 12-hour fast,
are above these "riormal limits" on three separate
occasions at least two weeks apart. Both cholesterol
and triglyceride serum concentrations increase gradually throughout childhood and adolescence. Although the studies are limited, the normal range of
cholesterol levels appears to be relatively narrow except during the first year of life when serum cholesterol is especially affected by the type of fat in the
diet; consequently, unless the parents are hyperlipemic, diagnostic and therapeutic decisions are best
delayed until after six months or one year of age,
when a more mixed source of dietary fat is usual and
there is a diminished variation of serum lipid concentrations. The changes in serum triglyceride concentrations during childhood are less well defined than
are those for cholesterol, although a gradual increase
is commonly observed. In children with persistent
hyperlipemia, serum lipoprotein should be estimated
by electrophoresis, and a survey of other family members is indicated. These additiona l studies can greatly
facilitate a precise diagnosis when it is possible to
demonstrate similar findings in a parent or sibling.
The most widely used classification of hyperlipemic diseases is based upon the serum lipoprotein
pattern since blood lipids are bound to lipoproteins.
The term "hyperlipoproteinemia" is therefore often
preferred over " hyperlipemia" or " hyperlipidemia."
Six types of primary hyperlipoproteinemia are seen in
adults; all except type III have been detected in childhood or adolescence. A useful classification of juvenile hyperlipoproteinemia is illustrated in the Figure.
Hyperlipoproteinemia I, also known as familial
hyperchylomicronemia or lipoprotein lipase deficiency, is a rare autosoma l recessive trait. The biochemical defect is a deficiency of the enzyme, lipoprotein lipase. In homozygous children the disease is
usually characterized by elevated cholesterol and triMC V QUARTERLY 13(4): 160-1 64, 1977
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TABLE 1
Upper Limits of "Normal" of Plasma Lipid and Lipoprotein Cholesterol Concentrations (mg/ 100 ml) in Infants, Children and Adolescents
TOTAL
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C HOLESTEROL
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IV
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11

II I I

11

I

Beta + Pre-Beta
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II
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II I I
II II I I

Chylomicrons
+ Pre-Beta

FEMALE

65

LI POPROTE IN
ELECTROPHORETIC
PATTERN

II 11

MALE

140

glyceride levels, a deficiency of lipoprotein lipase activity in post-heparin plasma or adipose tissue, chylomicron uptake in the skin and reticuloendothelial
tissue, abdominal pain, and pancreatitis which may
be fatal. In children with xanthoma or pain the diagnosis is clinically obvious. However, in many children
who are asymptomatic the diagnosis may be made
LIPOPROTEIN
PHENOTYPE

LDL CHOLESTE ROL

SERUM
CHOL.

t

accidentally by a finding of milky plasma, hepatosplenomegaly, or lipemia retinalis. Premature atherosclerosis has not been documented in these patients;
however, the other symptoms and debilitating nature
of the disease make treatment mandatory.
Hyperlipoproteinemia II, also know as familial
hypercholesterolemia or familial hyperbetalipoproLIPIDS
TRIGLY.

PRIMARY

SECONDARY

tttt

Familial
hyperchylomicronemia

Diabetes mellitus

Familial
hypercholesterolemia

Hypothyroidism
Nephrotic syndrome
Obstructive jaundice

t

LDL

ttt

t
t

LDL
VLDL

ttt

tt

Fami 11 al
hypercholesterolemia

Hypothyroidism
Nephrotic syndrome
Obstructive jaundice

ttt

ttt

Familial
dysbetalipoproteinemia

Hypothyroidism

+or -

ttt

Familial
hyperglyceridemia

Diabetes mellitus
Nephrotic syndrome
Glycogenosis (III)
Hypothyroidism

+++

tttt

Familial
hypertriglyceridemia

Diabetes mellitus
Nephrotic syndrome
Pancreatitis

Abn LDL
Abn ~-VLDL

t

VLDL

Chylomicrons
t VLDL

Figure-Phenotypic classification of hyperlipoproteinemias.

162
teinemia, is inherited as an autosomal dominant trait.
It is the most common form of juvenile hyperlipemia
a nd is associated with a high risk of premature coronary artery disease. Hyperlipoproteinemia II accounts for many adults with myocardial infarction.
Biochemical abnormalities are now believed to be the
result of an absence or deficiency of a low-density
lipoprotein receptor on cell membranes. 5·6
The relatively common heterozygous form, hyperlipoproteinemia II A, has an estimated prevalence
of four per thousand 7; in a Seattle study approximately one out of every twenty adult survivors of
myocardial infarction was found to have this condition8; in a similar study 38 of 64 survivors had abnormal lipoprotein patterns. 9 These hyperlipemic fathers, all under 41 years of age, had 85 children of
whom 30 also had hyperlipoproteinemia II. Heterozygous infants have plasma cholesterol levels that are
two to three times normal by the end of the first year
of life. In matings between a heterozygous and a
normal parent, the affected children can be identified
at birth by cord-blood elevations of low-density lipoprotein cholesterol to values greater than 41 mg/ JOO
ml. 10 Tendinous xanthoma, corneal arcus, and coronary artery disease develop in young adults, usually
from 20 to 30 years of age. In about I 0% of children
with type II disease, there are mildly elevated levels of
very low-density lipoproteins and triglycerides along
with elevations in low-density lipoprotein cholesterol.11 This less common variation is classified as
familial hyperlipoproteinemia II B. 12
Homozygous children, who inherit a double
dose of the mutant gene, are much more severely
affected; the disease is often suspected initially because of the strong family history of heart disease.
Cholesterol levels, which may range from 500 to JOOO
mg/ JOO ml, are frequently markedly elevated even at
birth, and corneal arcus and xanthoma appear before
adolescence. Coronary artery disease is clinically apparent before the age of 20 and survival beyond 30 is
rare.
In every family with a member who h as experienced a heart attack before the age of 50, serum
cholesterol and triglyceride levels should be measured
in all first-degree relatives. Those with normal lipid
values can be reassured about lipid risk factors and a
significant number of those with hyperlipemia can be
identified and treated early.
Hyperlipoproteinemia III , also known as "broad
Beta disease," "floating Beta disease," or dysbetalipoproteinemia, has not been detected in children,
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as noted previously. Inheritance is probably either
an autosomal recessive or an autosomal dominant
with incomplete penetrance.13 The condition results
in elevated levels of cholesterol and triglycerides with
an abnormal cholesterol to triglyceride ratio in the
very low-density lipoprotein . 14
Hyperlipoproteinemia IV, is relatively rare in
children and is also referred to as familial hypertriglyceridemia or endogenous hypertriglyceridemia.
Triglyceride levels a re always elevated, ranging from
150 to 1000 mg/ JOO ml, and in about 20% of patients
the very low-density lipoprotein levels may result in a
hypercholesterolemia, with levels up to 350 mg/ JOO
ml. 15 Clinical findings commonly include non-ketotic
diabetes and, less commonly, subcutaneous xanthoma . Obesity and hyperuricemia are frequent. A
significant proportion of adults under the age of 50
with angina or myocardial infarction have primary
type IV disease. 15 The condition appears to be heterogeneous. The biochemical abnormality is not known,
but studies suggest a defect in very low-density lipoproteinemia catabolism. 16·17 It may occur in relatives
of patients with type III or type V lipoprotein abnormalities13 and in some families genetic transmission
follows an autosomal dominant pattern with delayed
expression.
Hyperlipoproteinemia V is rare in childhood.
Triglyceride levels range from 500 to 6,500 mg/ JOO
ml and cholesterol varies from 150 to 1,500 mg/ JOO
ml. Clinical findings are similar to those with type I
disease. Type V disease does not lead to premature
atherosclerosis; it is frequently associated with obesity, hyperuricemia, a nd abnorma l glucose tolerance.
The inheritance of the primary disease is not known;
a family history of diabetes is common and there is a
high prevalence of type IV disease in first-degree relatives.
Many chronic childhood diseases are associated
with secondary hyperlipemia (Figure). Although infants with hypothyroidism usuall y have normal lipids
and lipoproteins, in older children hypothyroidism is
often associated with hypercholesterolemia which
can be reduced by adequate thyroid treatment. Most
children with the nephrotic syndrome have hypercholesterolemia, with close inverse correlations between cholesterol and albumin levels. In children
treated by renal dialysis, the practice of feeding high
fat diets to provide sufficient calories for growth may
result in secondary hyperlipoproteinemia and acceleration of atherosclerosis. Children with hepatic glycogenosis III have hyperlipoproteinemia, usually
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with increases in very low-density lipoproteins. Since
many of these children survive to adulthood, early
modification of the hyperlipemia by diet is indicated.
Children with obstructive liver disease often have
hyperlipemia unless the disease is at an advanced
stage. Diet a nd drug management of the hyperlipemia result in diminution in the symptoms and
lesions of xanthomatosis. In adolescents and young
adults other rare causes of hyperlipemia are pregnancy, alcoholism, adrenal disease, and the chronic
administration of adrenal corticosteroid drugs.
Dietary restriction and selection of fats is indicated in all children with primary hyperlipemias
(Table 2). Because skin xanthoma are diminished or
eliminated in children undergoing treatment, it is reasonable to conjecture that regression of vascular lipid
deposits, with a concomitantly decreased risk of corona ry artery disease, also occurs. In type I disease a
low-fat diet normalizes serum lipids and reduces or
prevents abdominal pain and pancreatitis. In type II
disease a low-fat, low-cholesterol diet with a high
ratio of polyunsaturated to saturated fats normalizes
lipids in type II A patients, reduces lipid levels significantly in type II B children, and diminishes xanthoma
in both. In type IV children a low-calorie, weightreduction diet is sufficient to normalize serum lipid.
In children with type V disease a low fat, moderate
cholesterol diet normalizes serum lipids and prevents
abdominal pain.

A low-cholesterol diet, 100 to 150 mg/ 100 ml, is
achieved by eliminating egg yolk, organ and fatty
meats, a nd shellfish, substituting skim milk and lowcholesterol margarine for whole milk and butter, using only cottage cheese among the cheeses and prohibiting products with coconut oil in them. 18
Diet management alone is inadequate in 85% of
type II children, and it is often necessary to u·se
cholestyramine, a nonabsorbable anionic resin and
bile acid sequestrant, which produces a n exchange of
chloride ions for bile acids in the intestine. The acids
are excreted in the feces, and the reduction in enzyme
product inhibition increases the endogenous metabolism of cholesterol, resulting in diminished serum
levels of very low-density and low-density lipoprotein
cholesterol. In doses of 250 to 800 mg/ kg/ day, cholestyramine does not cause malabsorption , although
constipation, epigastric discomfort, and bloating are
common. Because the drug absorbs fat, it can also
produce mild steatorrhea and poor absorption of fat
soluble vitamins. Its disagreeable taste is masked by
using fruit juice or incorporating it into cookies. The
surgical treatment of children with type II disease by
partial ilea! bypass is not recommended at this time.
In homozygous type II B children, the prognosis
for effective reduction in serum lipids is poor. Lowfat diets a nd la rge doses of cholestyramine, together
with the administration of nicotinic acid may be effective.19 Nicotinic acid, however, is often poorly tol-

TABLE 2
Treatment of Primary Juvenile Hyperlipemia
TYPE

DIET

DRUG

Low fat (10-15 g/ day)
Medium chain triglyceride
II A HETE RO ZYGOTE

II B HOMOZYGOTE

Low cholestero l (100-150 mg/day)
High polyunsaturated/
saturated ratio (2/ I)
Low cholesterol (100-150 mg/ day)
High polyunsatu rated/
saturated ratio (2/ 1)

EFFECT

No rm alizes lipids
Prevents pain and pancreatitis
Cholestyramine
(250- 800 mg/kg/ day)

Normalizes lipids. Reduction of
cardiovascular risk possible

Cho lestyram ine
500- I 500 mg/ kg/ day
Nicotinic acid
25-75 mg/ kg/ day

Lowers lipids, Xa nthoma diminish.
Reductio n of cardiovascular
risk possible

IV

Low calorie weight control

Norma lizes lipids. Red uction in
cardiovascu la r risk possible

v

Low fat (20-30 g/ day)
Moderate cholesterol
(300-400 mg/ kg/ day)
Medium chain triglyceride

Normalizes lipids prevents pain
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erated because of such side-effects as flushing , gastrointestinal distress, temporary hyperuricemia, glucose
intolerance, or hepatic dysfunction .
Nationwide reductions in dietary fat and cholesterol intake have been promulgated by various health
organizations. Most advisors recommend a reduction
of individual fat intake from 40% to 30% of the total
calories and a decrease in cholesterol and saturated
fats.
Juvenile hyperlipemia is relatively common in
the United States, and most affected children are
asymptomatic. Measurements of serum cholesterol
and triglycerides are indicated in all infants and children in families with one or more members having a
heart attack before the age of 50, because a significant proportion of these children will have hyperlipemia and will require dietary restrictions, and
some will need drug treatment. Early recognition and
management of juvenile hyperlipemia may diminish
the incidence or severity of coronary artery disease
decades later.
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V. RESEARCH

New Approaches to the Use of Twins in
Biomedical Research
WALTER E. NANCE, M.D., PH.D., Professor of Human Genetics, Pediatrics, and Medicine

Human genet1c1sts are often accused of being
preoccupied with exotic syndromes that are of marginal relevance to the general population. Brilliant
success has been achieved during the past two decades in defining the nature and function of the genetic
material, the molecular pathology of a large number
of metabolic diseases, the phenotype of inore than
2,000 Mendelian traits, and more recently the
chromosomal location of a rapidly expanding number of human gene pairs. In contrast, relatively little
progress has been made in the genetic analysis of
quantitative traits such as blood pressure, serum cholesterol, intelligence quotient (IQ), skin color, height,
birth weight, or glucose tolerance. Traits of this type
are not only of interest to society, but may also relate
significantly to a variety of common diseases. With
almost every continuously distributed quantitative
trait, single gene defects have been identified which
can profoundly alter the phenotype. For example, the
single gene pairs which determine albinism and TaySachs disease can profoundly alter skin color and IQ
respectively. However, the causes of less extreme variation can be exceedingly complex, resulting from the
cumulative effects of many gene pairs and their interactions with each other and with the environment.
Nevertheless, even if the effects of individual gene
pairs cannot be identified, the source of the observed
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variation may often be inferred from an analysis of
the phenotypic correlation of relatives of various degree. Twin studies have been widely used in the past
to gain insight into the inheritance · of quantitative
traits, and with the support of a Program Project
Grant from the National Institute of Maternal and
Child Health, the Department of Human Genetics at
the Medical College of Virginia has become a leader
in the use of twins for biomedical research.
The basic idea of a classical twin study is to
compare the differences between monozygotic (MZ)
and dizygotic (DZ) twins. Since MZ twins arise from
a single fertilized egg, they possess identical sets of
nuclear genes, and differences between them are assumed to arise from environmental causes. DZ twins,
on the other hand, are genetically no more similar
than siblings, sharing, on the average, only half of
their genes. The extent to which the intrapair differences of DZ twins exceed those of MZ twins provides
a measure of the importance of genetic factors as a
cause for variation in DZ twins. DZ twins are considered to be an appropriate comparison group because
they are born at the same time and are assumed to
share the same environmental similarities as MZ
twins . Classical twin studies remain a very useful
method for estimating the relative importance of genetic factors as a cause for variation in complex physical, physiological, or psychological traits . We have
made extensive use of this approach to investigate
the genetic control of bone mineral content, 1 dental
and cephalometric variables, 2 •3 •4 electrocardiographic
variables, 5 amino acid metabolism, 6 dermatoglyphic
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F.ig !-Pedigrees of families of monozygotic twins. Lines below
figures suggest how variation among the offspring may be partitioned into arnong half-sibship, between sibship within half-sibship, and within sibship components. Squares indicate males and
circles, females.

variables, 7 and a variety of biochemical, physiological, and psychological traits. 8 •9 • 10 However, there ar,e
a number of limitations in the classical twin model.
The method does not permit the recognition of maternal effects or an incisive resolution of the geneti(l
effects, and the assumption that the erivironmental
similarities of identical and fraternal twins are equivalent may be open to question for some traits.
Also , in order to generalize the results, we must be
willing to consider twins a random sample of the
genotypes iri the general population. This.is probably
a reasonaole assumption for ,, MZ twins; however,
many genetic and environmental factors are known
which profoundly influence the incidence of DZ twins
and might, therefore, prevent direct extrapolation of
the results of a twin study to the general population. 11
Finally, ooth fraternal and identical twins may be
exposed to. unique intrauterine environmental effects
which need to be better understood in order to evaluate their possible significance as a source of bias in
classical twin studies. 9
fo order to circumvent these problems, we have
developed a powerful new m.o del for the analysis of
quantitative inheritance in man which exploits the
unique relationships that exist withiri the families of
identical twins. 12 Because they have a genetically
identical parent, the children of identical twins are
related to each other in the same way as half-siblings
(Fig 1). Genetically, the child of a twin is just as
Closely related. tb his twin aunt or uncle as he is. to his
twin parent. However, since the parents and their
own children usually live in the same home, and are,
for example, exposed to the same diet, we would
expect any significant environmental similarities to
make an additional contribution to the parentcoffspring correlation. It is easy to see how a comparison
of the correlations would permit a clear separation of
genetic and environmental effects on the closely re-

lated half-sibs. Each family contains individuals who
share one fourth of their genes (the half-sibs ), one
half of their genes (the full sibs ), all of their genes (the
MZ twins), and none of their genes (the spouses of
the twins). These and other relationships permit the
derivation of multiple line_a r equations in which an
observed correlation, variance or covariance between
family members is expressed as a linear combination
of several unknown genetic and environmental variance components that we wish to estimate. Since the
!IlOdel yields more equations than unknowns, we can
solve the system of equations and obtain the best
fitting estimates of the unknown parameters. The
calculations are quite complicated, particularly since
we rrii.Jst allow for the fact that our observed correlations, variances, and covariances may not be independent of one another because they have been derived . from individuals who are interrelated in a
complex manner. However, the use of a high-speed
computer makes solution of the equations technically
feasible.
The entire process of parameters estimation can
be summarized in matrix n_o tation by the single equation, d = (M'V- 1 M)- 1 M' v- 1c. G represents the
vector of unknown genetic variance components we
wish to estimate; M represents the matrix of coefficients derived from Table 1; C represents the vector
of the ob~erved meah squares; and V represents the
variance/covariance matrix of the observed mean
squares. Most physicians would probably find a
detailed exposition of tfie mathematical analysis to
be tedious and uninformative; however , the essence
of the analysis is simple and intuitive, depending

TABLE I
Genetic Interpretation of Variance Components from
Offspring Analysis of Variance
Constituent genetic and
environmental subcomponents

Among haJfcsibship,
male twins
Between sibships,
male twins
With sibships
Between sibships,
female twins
Among half-sibships ,
female twins

l/ 16

0

1/ 4 1/ 4 3/ 16
1/ 2 3/ 4 3/ 4

l
0

0
0

1/ 4 1/ 4 3/ 16

0

0

1/ 4

1/ 4

0

0

1/ 16

0

0

l
0

0

0
0

0
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TABLE 2
Analysis of the Birth Weight of 254 Offspring of 46 Pairs
of Identical Twins

Parameter

YAA
YM
YES
YEW

Estimate±
Standard Error

0.014
0.075
0.049
0.082

± 0.037
± 0.030
± 0.020
± 0.028

Prbportion of total
variance(%)

6.4
34.1
22.2
37.3

as it does upon the concept developed in high school
algebra, that if you have as mahy independent
equations as you have unknowns, a solution can be
obtained.
A unique feature of the model is that it permits
the detection and estimation of genetically determined maternal effects. If intrauterine or postnatal
maternal effects influence a trait to a significant degree, we would expect the .offspring of identical female twins to be more similar than the offspring of
male twins sinC'e the latter are born to genetically
unrelated mothers. As suggested by Figure l, the
total variability or variance among the offspring may
be divided by a statistical procedure known as a
"riested analysis of variance'.' into withih sibship, between sibship within half-sibship, and among halfsibship components. Each of these components may
be expressed in terms of a series of constituent genetic
and environmental subcomponents (Table l ). In this
formulation, VA refers tO the additive component of
the genetic variance. Additive genetic effects are the
ones responsible for the resemblance between parents
and their offspring. The among half-sibship component of variance is equivalent to the covariance 6f
half-sibs and since half-sibs share one fourth of their
genes, this component includes one fourth of the total
variation attributable to additive effects, the remainder being distributed as shown in Table l. VAA refers
to additive genetic effects that result from the interaction of gehes at separate loci. The term V0 refers to
genetic effects that show dominance and arise from
interactions bet:Ween the two members of a gene p~ir
(alleles). Dominance effects cari contribute to the
similarity only of individuals who are related to each
other through both parents. For this reason, note
that no dominance effects appear in the among halfsibship component. YEH• VEs, and VEw refer to
environmental effeets acting among haif-sibships, between sibships within half-sibships, and within sibships respectivel,y. Finally, maternal effects are desig-

nated by VM· Since they contribute to the similarity of
the half-sib offspring of female twins, VM appears in
the among half-sibship component for female twins.
In the case of male twins, on the other hand, the
maternal effects arising from the genetically unrelated
wives contribute to variation between sibships within
each half-sibship. The five relationships shown in
Table 1 provide five of the equations which can be
used in the overall analysis described previously. If
the analysis is confined to these relationships, it becomes possible to exploit the unique genetic relationship of moriozygotic twins through observations of
their offspring without incurring any of the methodologic liabilities that might be associated with the
inclusion of data from the twins themselves.
Table 2 shows the results of an analysis of the
birth weight of 254 children of 46 twin pairs. The data
were collected by interviews and questionnaires, and
prior to the analysis, the birth weights were adjusted
for gestational age at the time of delivery. In all
genetic models that fit the data well, there was evidence that genetically determined maternal effects
made a highly significant contribution to the overall
variation in birth weight. In fact, our results suggest
that at least one third of the total variation in birth
weight is actually fixed or determined prior to the
time of conception by the genotype of the mother!
Since birth weight is highly correlated with feta l survival, these findings raise the possibility that perhaps
we should look more closely at the mothers of high
and low birth weight infants; in future extensions of
the present work, we would like to repeat the analysis
TABLE 3
Distribution of Twins by Age, Sex, and Zygosity
Age in years
T ype

0-10

10-20

20

Total

15
14

II

3

6
10

32
27

29

14

16

59

9
9
21

I

2

0
3
2

10
13
25

39

4

5

48

68

18

21

107

MONOZYGOTI C

Male-M a le
Fema le-Fem a le
Total
DIZYGOTIC

Male-Male
Female-Female
Male-Female
Total

GRA N D TOTAL
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TABLE 4
Distribution of Newborn Twins by Race and Placenta Type
Black
Placenta type

White

Total

MZ DZ MZ DZ MZ DZ

TWINS

Monochorionic
monoamnionic
Monochorionic diamnionic
Dichorionic, fused
Dichorionic, separate

0
0
4
16

0
2
0
0

0
0
4
5

1
8

1
0

0

0
0

0
0

1
0

10

21

2

9

I
6

0
0
8
21

TRIPLETS

Monochorionic triamnionic
Trichorionic
TOTAL

12

0
30

after dividing the families into high, low, and inte!mediate birth weight categories. We are currently
trying to identify additional fertile adult MZ twins
who would be suitable for inclusion in our MZ halfsib studies . The project involves the collection of. a
large amount of medical and genetic data from the
families during an out-patient visit, and the participants are informed of any abnormalities that are
detected in any of the blood, urine, or physiologic
screening tests.*

Biology of Twinning
Since the new program of twin research was
initiated at MCV, 107 twin pairs have been evaluated

* Twins may be referred to the study by calling the Project Coordinator, Phyllis Winter, at 804/ 770-4645.

Pedigrees of Familial Twinning

#1020'

-----'--

~J
#1794

#1361

Fig 2-Pedigrees of 15 families showing a history of twinning in close relatives.

#1353
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and enrolled in the Twin Panel (Table 3). The sample
includes 40 pairs of newborn twins and two sets of
triplets ascertained from the MCV Obstetrical Service. Systematic placental examinations have been
performed in these twins (Table 4 ). It is now clear
that monozygotic twins may have either two separate
placentas or a single placenta. The former are all
dichorionic while the latter include dichorionic pairs
and monochorionic twins that may either be diamnionic or rarely monoamnionic. These differences in
placentation are thought to reflect differences in the
stage of embryonic life at which the twinning process
occurred. One goal of the newborn twin study is to
determine whether these striking placental differences
are reflected in phenotypic differences between the
twins. Preliminary evidence suggests that the intrapair differences in cord blood cholesterol in dichorionic twins are more than five times as great as those
observed in monochorionic pairs. 9
The twins studied to date have included 15 families in which there was a history of twinning in a close
relative (Fig 2). A genetic predisposition to dizygotic
twinning has long been recognized, presumably mediated by neuroendocrine differences in some women.
For MZ twins, however, it is much less clear whether
or not the occasional occurrence of familial aggregation indicates a genetic effect, and the cases shown
(see Fig 2) do little to resolve this uncertainty. In
family #1885, the birth of two sets of MZ twins to a
woman by different fathers strongly suggests a maternal influence, whereas family #1836, in which MZ
twins were born to a member of a male MZ pair,
suggests patrilineal inheritance. Finally, in family
#1642, placental examinations were performed on
both twin pairs, revealing monoamnionic placentation in one and diamnionic monochorionic placentation in the other-a finding which suggests that familial occurrence is not confined to twins of a single
placenta type.

novative research, and it is intended that the Panel be
a research resource for clinical investigators at the
Medical Center.
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The MCV Twin Panel was begun in 1976 and
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ages. Twin studies offer many opportunities for in-
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In experimental animals where the generation
time is short and matings can be controlled experimentally, it is a relatively simple task to determine
whether a trait is genetic, how it is inherited, a nd
where the causal gene pair is located. However, in
human genetics, inferences must be drawn by pooling
observations on many small families in which the
trait of interest has occurred. The condition may be
etiologically heterogeneous, resulting from environmental causes in some families and showing variable
patterns of inheritance in others. Hereditary deafness
and retinitis pigmentosa (RP) provide instructive examples of the problems involved in the genetic analysis of family data in man.
Hereditary Deafness
It is now clear that the interactions of literally
hundreds of genes are required to provide the information needed to form a normal ear, and that a
defect in any one of many genes can result in deafness.1 Well over 100 specific syndromes have been
described showing domina nt, recessive, and sexlinked patterns of genetic transmission in which hea ring loss is a major fi nding. 2 On the other hand, many
environmental causes of deafness are known, such as
rubella, prematurity, and ototoxicity, and in a given
case, in the absence of a recognizable syndrome or a
positive family history, it may be difficult to be sure
whether the cause is genetic or nongenetic.
The problem is complicated by the fact that huThis is paper #32 from the Department of Human Genetics of
the Medical College of Virginia.
Correspondence and reprint requests to Joann Boughma n,
Box 33, Medical College of Virginia, Richmond, Virginia 23298.
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man families are so small that with recessive deafness
(the most common genetic type) there may be only
one affected child in the family. Table 1 shows the
expected proportion of families that would have no
affected children, one affected child (simplex families), and more than one affected child (multiplex
families), with a recessive trait. The multiplex families are the "obvious" genetic cases, and the task of
the geneticist is to estimate what proportion of the
simplex families are, in fact, genetic cases in which by
chance only o ne affected child has occurred. The
remaining simplex cases are sporadic; they arise from
nongenetic causes and are not associated with an
appreciable recurrence risk. The proportion of nongenetic or sporadic cases is designated by the letter x.
A second problem in the analysis of data from human
families relates to ascertainment biases. In the case of
a recessive trait, a large proportion of the families at
risk will have no affected children (Table 1). Since
there may be no way for us to discover these families,
we must base our conclusions about the expected
proportion of affected children on an incomplete or
truncated sample of families which has been ascertained because there has been at least one affected
child in the family . In order to accurately estimate the
recurrence risk, we must allow, in an appropriate
manner, for the families with no affected children
that we had no way of discovering.
The parameter 7r is the probability that an affected individual will be independently discovered by
the sampling procedure. The value of 7r can vary from
nearly zero to one and is a measure of the completeness of the sampling procedure. Finally, we wish to
estimate p, the recurrence risk or segregation ratio. If
the estimate of p is close to 0.25, we might conclude.
MCV QUARTERLY 13(4): 170-174, 1977
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TABLE I
Expected Proportion of Families with no Affected,
One Affected, and Multiple
Affected Offspring in Matings
Between Carriers of a Recessive Gene.
FAMILIES WITH AFFECTED
FAM ILI ES

C HILDRE N

(o/o )

WITH NO
NUMBER OF

AFFECTED

CHILDREN

CH ILDRE N

O NE

THAN ONE

MORE

IN FAMILY

(%)

(SIMPLEX)

(MULTIPLEX)

2
3
4
5
6
7
8

75
56
42
32
24
18
13
10

25
37
42
42
40
35
31
27

0
7
16
26
36
47
56
63

that the data agreed satisfactorily with the hypothesis
of recessive inheritance.
The process by which the three parameters ?r, x ,
and pare estimated is known as segregation analysis. 3
With the use of a high-speed computer, we can estimate what values of x, ?r, and p provide the best
explanation for any given set of data containing information on the number of affected and normal
individuals and index cases in each of a large series of
families.
The results of segregation analysis of data from
11 ,968 families of deaf children are shown in Table 2.
In the first line we see that in the case of 86 consanguineous matings, the hypothesis of recessive in-

heritance with no sporadic cases (that is, p=0.25 and
x= O.O) provides a satisfactory explanation for the
data. The relatively low X 2 values in the last two
columns indicate a good fit of the hypothesis to the
data. This means that whenever we elicit a history of
consanguinity, it is safe to assume that we are dealing
with recessive deafness even if there is only one affected child in the family. This result is not surprising
since parental consanguinity is the hallmark of recessive inheritance. When present, it may indicate that
the affected child has inherited two copies of the same
rare recessive gene carried by one of the common
ancestors of the parents.
In the second and forth lines, we see that the
hypothesis that all of the children in 11 ,900 nonconsanguineous matings have recessive deafness is
resoundingly rejected as indicated by the enormous
X 2 values. However, when we allow x to assume the
best fitting value of 0.6 in the families with a negative
family history, the hypothesis that the remaining
cases are recessive (that is, p=0.25) fits very well
indeed (line three) . This tells us that among these
nonconsanguineous families, 40% are genetic and
probably recessive while 60% are nongenetic. It is of
considerable interest that among families in which
there was a remote history of deafness, in a grandparent, a unt, uncle, or a cousin for example, the
estimated proportion of sporadic or nongenetic cases
was much smaller (x=0.2), as shown in line five.
Similar analysis can be performed for deaf children
arising from deaf by normal matings, which presumably are attributable to dominant inheritance, as well
as for affected children arising from deaf by deaf
matings, which may include both dominant and re-

TABLE 2
Results of Segregation Analysis on 11,986 Hearing X Hearing Matings with Deaf Children (7r = 0.325 )
N UMBER OF CHILDREN
MATING TYPE AND

NUMBER OF

HYPOTHESIS TESTE D

SIBSHIPS

Hearing X hearing
consanguineous
H0 : p = 0.25, x = 0

DEAF

xx

HEARING

2

86

150

148

2.1

3.4

Negative family history
H0 : p = 0.25, x = 0
H 0 : p = 0.25, = 0.6

10,509
10,509

12,7 12
12,712

28,739
28, 739

5,289.6
1.9

5,832.8

Positive family history
H 0 : p = 0.25, x = 0
H,: p = 0.25, x = .2

1,391
1,391

2,142
2,142

3,496
3,496

97.0
0.05

103.9

x
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TABLE 3
Summary Results of Segregation Analysis in 12,661 Informative Families with Deaf Children.
CHILDREN WITH GENETIC DEAFNESS
NUMBER OF

NUMBER OF

CHILDREN WITY

MATING TYPE

FAMILIES

DEAF CHILDREN

SPORADIC DEAFNESS

Hearing X hearing
DeafX hearing
DeafX deaf

11,986
254
421

15,004
478
989

8,126
0
0

6,650
0
451

228
478
538

TOTAL

12,661

16,471

8,126

7, 101

1,244

49.3

43.1
85. 1

7.6
14.9

% of Total
% of Genetic

cessive phenotypes. Table 3 provides a tally sheet for
the segregation analysis of a large sample of l 6,4 7 l
deaf children. Although there were multiple affected
children in only about 6% of the families, it can be
seen that our best estimate is that almost exactly half
of the cases are in fact genetic in etiology. Most
educators and physicians who work with the deaf
find this estimate to be surprisingly high. Few
otolaryngologists consider themselves to be geneticists in spite of the fact that half of the young children
they see with profound hearing loss are deaf because
of genetic reasons. The frequency of patients with
simply inherited genetic traits in this group is actually
larger than that observed among children who are
referred to a typical human genetics clinic for evaluation and counseling.'
Unfortunately, it is not always possible to identify those simplex cases that are genetic. As an aid to
diagnosis in these cases, we have begun to establish a
Genetic Registry of Hereditary Deafness. The Registry is based upon pedigree data from a sample of
about 5,000 matings among the deaf that were collected by E. A. Fay, a professor of Gallaudet College
in Washington, D.C., before the turn of the century.
The Registry contains detailed information on about
30,000 individuals that was collected by Fay and is
supplemented by data on current pedigrees. In about
7% of patients with genetic deafness, we find that it is
possible to establish a geneologic linkage with someone listed in the Registry. Thus in some cases, use of
the Registry can help establish the genetic nature of
the disorder in situations where it might not be apparent from the clinical evaluation or the immediate
family history.
The Registry should also promote the recognition of genetic heterogeneity which, as previously
mentioned, is known to be extensive in hereditary

RECESSIV E

DOMINANT

deafness. An autosomal recessive form of hereditary
deafness known as Usher syndrome provides an excellent example of heterogeneity even within a single
clinical entity. In this condition affected persons suffer from progressive blindness due to retinitis pigmentosa (RP) in addition to sensorineural hearing
loss. Our studies suggest that the classic delineation
of Usher syndrome with early-onset, severe sensorineural deafness and RP may have to be modified.
We are collecting data on affected individuals
using two different methods of ascertainment. The
first involves ophthalmologic screening of students in
schools for the deaf. About 4% to 6% of this group
have an associated RP. Since these students tend to
have severe hearing loss, our ascertainment is biased
with regard to degree of hearing loss. To circumvent
this problem we are also documenting the hearing
status of a population of affected patients identified
through the National Retinitis Pigmentosa Foundation. Our preliminary data indicate that considerable
clinical and genetic heterogeneity exist in these families.5 Of great interest is the disparity in degree of
hearing loss in probands and their affected sibs in the
multiplex sibships. Table 4 shows that in 29 sibships

TABLE 4
Hearing Loss in Affected Sibs of Probands
DEGREE OF HEARING LOSS IN AFFECTED
DEGREE OF

SIBS OF PROBANDS*

HEARING LOSS
IN PROBANDS

NONE

Mild
Severe

MILD

SEVERE

21

8

0

8

6

I

* numbers refer to sibships
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TABLE 5
Syndromes Characterized by Retinitis Pigmentosa (RP)

NAME

MODE OF
INHERITANCE SOM E TYPICAL FINDINGS

Usher
Refs um

AR
AR

Bassen-K ornzweig

AR

Laurence-MoonBardet-Biedl

AR

Cockayne

AR

Profound deafness; RP
Neuropathies; EKG
abnormalities; ichthyosis;
deafness; RP; hyposmia
Abetalipoproteinemia;
RP; acanthocytosis;
gastrointestinal disease
Mental retardation;
obesity; polydactyly;
hypogonadism; RP
Dwarfism; mental
retardation; hearing loss;
unusual facies; RP;
derm atitis

the probands had either mild or severe hearing loss,
but the sibs affected with RP had no hearing loss; and
in six sibships the probands reported severe hearing
loss while the sibs had only a mild loss.
Thus Usher syndrome may represent only part
of a broad clinical spectrum of disability involving
these two sensory modalities, and our Registry
should not only promote the recognition of such
heterogeneity but improve the quality of medical ,
genetic, and educational research on such diseases by
providing rosters of affected individuals who are etiologically homogeneous.
Retinitis Pigmentosa
The term retinitis pigmentosa refers to a group
of genetic disorders in which there is a progressive
loss of vision associated with a characteristic pigmentary degeneration of the retina, nycta lopia, and
progressive loss of peripheral vision, often leading to

blindness. The genetic h eterogeneity of this group of
disorders is well documented . First, it is known that
RP may be inherited in all three Mendelian modes:
recessive (80% to 90% of cases), dominant (5% to
10%), and X-linked (1% to 5%). 6 Second, several
specific genetic syndromes, of which RP is a part,
have been identified (Table 5). More evidence for
genetic heterogeneity comes from the study of many
animal models for RP which indicate that the phenotype seen in these degenerative disorders may be
produced by various primary lesions. 7
In collaboration with the Na ti on al Retinitis Pigmentosa Foundation, we are conducting a nationwide survey in order to clinically and genetically
characterize a sample of pro bands with RP. Systematic questionnaire data on family history, age of onset
and progression of the symptoms, and associated abnormalities, have been analyzed on 670 individuals,
forming a data base of 12,348 members of families
including 1,390 affected individuals.
Nyctalopia was the most frequently noticed first
symptom, especially in the younger age groups. The
most common extraocular finding was hearing loss,
reported by 30.4% of the pro bands, 10.6% indicating
their loss was severe. This finding in our large proband sample reemphasizes the association between
hearing loss a nd RP.
Segregation analysis has been performed on 405
informative proband sibships with no recognizable
syndromes. Table 6 summarizes the results of these
analyses, showing estimates of the segregation frequency and proportion of sporadic ( nongenetic)
cases. The estimate of penetrance in the case of the
dominant mode of inheritance was 0.58. The finding
of a low segregation ratio fo r both the recessive and
dominant forms of RP is not surprising in view of the
natural history of these disorders. The decreases in
these ratios reflect the fact that the age of onset may
not have been reached by ma ny sibs, the median
onset age for probands being nearly 15 years. Perha ps

TABLE 6
Segregation Analysis on Retinitis Pigmentosa Sibships

MATING TYPE
Normal X Norma l Nonconsa nguineo us
Normal X Normal Consangu ineous
Normal X Affected

NUMBER OF
SIBSHI PS

SEGREGATION RA TIO

PROPORTION
SPORADIC CASES

PENTRANCE

312
18
71

0.17±.06
0.45±.12
0.29 ± .04

0.11
0
0

0.58
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the most significant finding from the segregation
analysis is the evidence it provides that a small proportion of the cases are nongenetic in etiology.
In conclusion, genetic registries, such as the one
described in this article, could have a nationwide
impact on the diagnosis of hereditary disease and on
genetic counseling for affected individuals and their
families. Our research applies an innovative technique for the diagnosis of genetic diseases that could
serve as a prototype to demonstrate the practical
value of categoric genetic registries. This research will
almost certainly lead to the recognition of new forms
of hereditary deafness and retinitis pigmentosa which
could be the first step in the development of specific
therapies.
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The Genetic and Environmental Effects on
Diabetes in Humans and Animals: An
Overview
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Despite intense scrutiny the precise etiology of
diabetes mellitus remains unclear. There appear to be
two major forms of diabetes: juvenile-onset or inCorrespondence and reprint requests to Dr. Roger M. Loria ,
Box 847, Medical College of Virginia , Richmond , Virgini a 23298.

sulin-dependent diabetes, and late-onset or irisulinindependent d.iabetes 1• 2 ; the late-onset form, in itself,
may be etiolbgically heterogenedus. 3 Either form may
occur at any age, with a ciear distinction between the
two often being difficult to rriake. Juvenile-onset diabetes, representing 5% to 10% of all cases, is charac-
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terized by abrupt qnset, clinical manifestation of hyperglycemi~ and ketoacidosis, and generally by a
requirement for exogenous insµlin; in maturity-onset
diabetes plasma levels of insulin are usually normal
or elevated and the abnor'rnality in gluco&e metabolism re&ults from a decrease in the number of insulin
receptors rather than a deficiency of the hormone
itself.

Genetics of Diabetes in Man
· It is generally accepted that there is an hert?diH!fM
predisposition to diab.etes, but there is little 'cagr~!ef:
ment as to its mode of inheritance. Early investiga~
tors concluded that diabetes was inhe~ited in a ~ii'npfe
Mendelian fashion, probably as an autosomal rece~
sive trait. 4 Subsequent studies, however, suggest that
diabetes may be controlled by a number of genes
whose final expression is influenced to varying degrees by the environment.5 It is still impossible to
resolve the multifactorial versus monogenic con.troversy from the data and analytical methodologies.

.
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now available. Diabetes is undoubtedly heterogeneous and this fact, as well as the late age of onset
in many cases, greatly complicates genetic analysis.
For eirnmple, striking differences in concordance rate
among identical twin pairs who have late-onset diabetes (92%) compared with identical twins with earlyonset diabetes (52%) provide strong evidence that the
two forms are etiologically distinct. 6 Concordant juvenile-onset pairs also had a positive family history of
diabetes more frequently than discordant pairs, suggesting that some cases are predominantly genetic,
and others environmental, in etiology.a

Genetics of Spontaneous Diabetes Mellitus in Animal
Models
A variety of animal models with spontaneous
diabetes mellitus have been reported in the literature6 •
1.s (Table I). Apparently many different mutations
can lead to spontaneous diabetes. Simple autosomal
recessive inheritance is displayed in db/ db, ob/ ob,

TABLE I
Genetics and Pathophysiological Changes in Animals with Spontaneous Diabetes

Animal Name

Mutation &
Chromosome
number

Inheritance

Obesity

Hyperglycemia

Elevated Serum
Insulin

Ketosis

Changes
in Islet

++

++

Diabetes
C57BIKs

db/ db
4

Autosomal recessive

++

+++

Obese
C57B I/6

ob/ob
6

Autosomal recessive

++

+

++

++

Yellow

A Va

Autosomal dominant

++

+

+

+

KK mouse

Polygenic

+

+

+

NZO

Polygenic

++

+

+

PBB/ Ld

Polygenic (?)

++

C,HfX I

Hybrids (fi)

+

++

+

Spiny mouse

Polygenic

+

+++

++

+

++

Sand rat

Polygenic

+

+++

transient

+

+

Autosomal recessive

++

+

++

+

+

+

Zucker rat

fa/ fa

+

transient+

+
+

+

Chinese hamster

Polygenic (4 genes)

+++

transient

S. African hamster

Polygenic

+++

(?)
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and fa/fa rodents; autosomal dominant AY inheritance is apparent in the yellow mouse; and finally,
polygenic inheritance has been invoked for the KK,
NZO, PBB/ Ld mice strains, rats, and hamsters.
The clinical syndromes expressed by these rodent models will in most cases involve obesity and/ or
hyperglycemia as seen in the db/db, ob/ob mice, and
the fa / fa rat with or without ketosis; hyperglycemia
without obesity is evident in the Chinese and South
African hamster; while marked obesity without overt
diabetes was displayed in ob/ ob, AY, NZO, PBB/Ld
mice, and the Zucker rat. This wide range of symptoms illustrates the difficulty in determining whether
genetic, environmental or maternal factors are the
primary determinants in this disease.
It now seems clear that even where diabetes is
associated with a specific mutation, that is, db/db in
the C57B I /KsJ mouse, other genetic and/ or environmental factors, such as genetic modifiers or viral infection, may be crucial in initiating this disease. The
ob/ ob (obese) mutation in the C57Bl / 6J inbred
mouse leads to obesity without diabetes . Transfer of
this mutation to the C57Bl/Ks inbred mouse strain
resulted in a C57B 1/ Ks ob/ ob animal with a metabolic disorder strikingly similar to the diabetic mutant (db/ db) itseJf. 9 These results clearly indicate that
two separate mutations which are known to be located on different chromosomes can give rise to indistinguishable phenotypes when placed on the appropriate genetic background.
Environmental Factors in Diabetes Mellitus
Environmental factors such as dietary intake, 10
gross obesity, 11 pregnancy, increased levels of estrogen in females, 12 and other endocrine changes have
been correlated with onset of diabetes mellitus. Finally, infectious agents such as congenital rubella,
group B coxsackieviruses, and mumps have also been
shown to be associated with this syndrome. 13 There is
good reason to believe that congenital rubella may
lead to diabetes mellitus in up to 20% of children who
have been infected in utero. 14 Similarly, mumps virus
has long been recognized as a cause of pancreatitis in
man, and scattered reports suggest that persistent
diabetes mellitus may sometimes appear one to eight
weeks after infection. 14 ·15
Presently, three experimental models for virusinduced diabetes have been reported in the literature.
The first involves infection by an unknown virus in
the guinea pig 16 ; the second model involves the experimental infection of mice with encephalomyocarditis

(EMC) virus which specifically destroys B cells of the
pancreas. 13 ·11 - 19 Susceptibility appears to depend on
genetic factors; some inbred strains are highly susceptible and others are not. These data clearly demonstrate that a viral agent belonging to the picornavirus
group, can induce diabetes mellitus in susceptible
animals. The third model system involves coxsackievirus B infection of the diabetic mutant mouse. Presently the best candidate for a causative viral agent of
diabetes mellitus in man is coxsackievirus B. This
agent has pancreatropic properties both in mice and
humans 20 and coxsackievirus B4 has been demonstrated in both the exocrine and endocrine sections of
the pancreas in human newborns with encephalohepatomyocarditis.21 In addition, extensive epidemiological studies have established a correlation between
coxsackievirus B4 infection and acute-onset diabetes
mellitus. 22
Recent studies carried out by one of us have
shown that the db mutation in the mouse causes a
significant increase in susceptibility to coxsackievirus
B4, and a dose-effect correlation between the virus
and the diabetes mutation was evident. These observations were well supported by histopathological
findings of the pancreata of animals infected with this
virus (Table 2). 23
These two animal models (EMC and coxsackievirus B4) involving picornavirus infection demonstrate how genetic factors can interact with the environment to cause diabetes. In the EMC virus model
the nature of the genetic predisposition of the host is
unknown, but is thought to be a recessive trait involving more than one gene. 19 ·20 In contrast, the findings in the mouse demonstrate that a single mutation
at the db locus is responsible for the increased susceptibility to diabetes in coxsackievirus B4 infection.
Histocompatibility and Immune Factors in Diabetes
Renewed support for the hypothesis that immune mechanisms may have an etiological role in
diabetes mellitus has been provided from the association between the histocompatibility antigens
HLA-B8, WI 5, CW3, and HLA-D with diabetes mellitus.16·24 - 27 The possibility that HLA-genes predispose the host to virus infection, resulting in B cell
destruction and insulin-dependent diabetes has been
suggested. Alternatively, the HLA-genes may be involved in the induction of autoimmune responses,
which again may have been triggered by virus infection.2·15·21 The latter alternative is supported by the
observation that the diabetogenic HLA-08 marker
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TABLE 2
Coxsackievirus 84 Edwards Infection in the Inbred Diabetic and Normal C57BIKs Mouse

% Mortality ofCB4' Infected Animal
Virus Dose in PFU' Animal

Histopathological Findings
Pancreas Necrosis
Acinar

Islets

JOO

+4

+4

90
50

+4
+I

Animal Genotype3

10'

10'

10'

db/ db
db/ +

JOO

JOO

10

50

+!+

JO

JO

Islet
Inflammatory
Degran ulation
Response
+4
+4

+4

CB4E = Coxsackievirus B4 Edwards.
PF U = plaque forming units.
'C57 BI Ks inbred mice with the specific mutation were used . The db/ db animals displayed on ly chemical diabetes; food intake was
monitored and regulated.
1

2

has also been associated with an increase in autoimmune diseases. 28 Finally, the evidence for, and significance of, autoimmunity in diabetes is still highly debatable and little information on the regenerative
properties or repair mechanisms of B cells is available.
In summary, the evidence presented argues for
genetic, environmental (viral), and immunological
factors in diabetes mellitus. The complexity of the
genetic factors in this syndrome is further emphasized
by the heterogeneous nature of the disease itself,
which may represent many different genetic entities.
Insulin-dependent and insulin-independent diabetes
mellitus may each be etiologically heterogeneous.
Understanding of the interaction between genetic and
environmental factors will permit the evaluation of
their respective roles in the etiology of this syndrome.
Table I is adapted from Renold et a11 and Hunt et al.'
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VI. CASE REPORTS

Syndrome Identification
What's in a name? This question is often asked
of a genetic counselor when a syndrome is newly
delineated. The brief case reports that follow demonstrate the importance of establishing precise diagnoses. They also emphasize that many of these syndromes are recognizable only after careful physical
examination of the proband and family members,

consultation with other subspecialties (for example,
neurology, radiology, orthopedics, dentistry, pathology), and a review of the medical literature.
While it is true that there usually is no treatment
for the basic condition, complications can often be
anticipated and serious consequences averted . Thus,
the diagnosis of Pierre Robin anomalad forewarns
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the physician of the risk of airway obstruction in the
prone position and of feeding difficulties in early
infancy. Knowledge of cervical spine anomalies in
chondrodystrophy alerts the neurologist to central
nervous system signs or symptoms that may result
from basilar brain compression .
A second benefit of syndrome identification is
that a better prognosis regarding such important factors as longevity, morbidity, and ultimate adult
height and mentality may be made. The dysmorphic
infant with Saethre-Chotzen syndrome is not at substantial risk for mental retardation. Recognition of
the earlier signs and dominant nature of the familial
form of amyotrophic lateral sclerosis enables better
counseling regarding longevity and morbidity.
Knowledge of the mode of inheritance provides
risk figures for recurrence so that family planning can
be practiced. It is not sufficient to state that the
patient with a dominant condition has a 50% risk that
each offspring will inherit the disorder; as demonstrated in the families with Pierre Robin anomalad
and Saethre-Chotzen syndrome, some persons have

minimal manifestations, thus reducing the significance of the existence of the condition. In the case of
sex-linked diseases, as in the family with chondrodystrophy, identification of female carriers can establish
a 50% risk that male offspring will inherit the disorder. Further studies in the family with ring 9
chromosome abnormality should establish whether
the proband, her mother, or other family members
are at risk for bearing anomalous offspring.
Often patients seen in our clinic have been evaluated elsewhere for one or more components (for
example, short stature, dysmorphic features, mental
retardation, congenital malformations) of their disorder, but a precise diagnosis has not been made.
Identifying the syndrome provides a diagnosis and
permits a proper focusing on the disease process.
While evaluation is often time-consuming, the reward
is a family gratified by the establishment of a diagnosis that will allow a better understanding of the condition.
PETER MAMUNES , M.D .

Professor of Pediatrics and of Human Genetics

A Report of Familial Ring (9) Chromosome
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Ring chromosomes ongmate in the simultaneous occurrence of two breaks at opposite ends of the
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chromosome and the subsequent reuniting of the free
ends to form a ring. They may be compatible with
normal life, as only a fractional loss of genetic material has occurred, or they may lead to spontaneous
abortion or to an offspring with severe physical a nd
mental handicap attributable to significant genetic
alterations.
The dearth of published case reports underscores
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Figure-(Top left) Pedigree of the proband. (Bottom left) Proband's karyotype, showing the ring chromosome (9) (arrow). (Top right)
Photograph of proband and mother. (Bottom right) Partial karyotype of proband's mother, showing the familial ring (9) (Chromosome
magnification, X4000).

the rarity of familial ring chromosomes. De novo ring
chromosomes have been described in all chromosome
groups in man, 1 but familial transmission of rings has
been limited to chromosome 17, 2 chromosome 18, 3
chromosome 21, Palmer et al 4 and by E. Engel, MD
(oral communication, May 1977), and a G-group
chromosome not identified by banding analysis. 5
Since the formation of a ring chromosome results in the loss of genes, it is not surprising that the
phenotype of the individual possessing the ring can
resemble the phenotype resulting from isolated short
or long arm deletions, a combination of both, or
duplications of the short or long arm due to recombination during meiosis.
Case Reports
Case I [Figure (top left, ll!,5) and (top right)] : P.S. was
the product of a 28-week gestation of a 24-year-old para 1,
gravida 1, abortion 0 mother who developed severe tox-

emia accompanied by a sudden decrease in estriol level.
Because of fetal distress, a Caesarian section was performed, and a 1,360 gm female was delivered on May I,
1974. The baby sat alone at eight months, walked at 18
months, and had a vocabulary of three to four words at 18
months. Jn September 1975, she was referred by a pediatrician to the Medical College of Virginia for evaluation of her
failure to thrive. Her length was 28 cm, weight 6,914 gm,
and head circumference 39 cm (all below the third percentile); she showed slight bilateral epicanthal folds and norm al
ears. Other tests revealed a bone age of 12 months, normal
skull films, 10/ 10 arches on dermatoglyphic analysis, normal intravenous pyelogram, normal sweat chloride, and a
normal Denver Development Test.
The patient was reexamined in the Genetics Counseling
Clinic on March 10, 1976. At that time her developmental
age on the Denver Development Test was 14 months (8
months under chronological age), her vocabulary still contained only four words, and she still was not toilet-trained.
Examination revealed an alert, active female child with
microcephaly, proportionate small size, large but not simple
or low-set ears, pointed teeth, prominent nose, wide down-
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turned mouth, slight epicanthal folds, and no congenital
heart defects. Her skull bones were fused.
The patient returned to the Genetics Counseling Clinic
at MCV on April 15, 1977, when she weighed 9,525 gm,
with a height of 85 cm. Her vocabulary had increased to
about 12 words and one three-word sentence. Thyroid studies showed T,, T,, and serum-free thyroxin to be within
normal limits.
Case 2 [Figure (top left, ll,5) and (top right) ]: C.S. is a
27-year-old female and the mother of Case I. Her medical
history includes an appendectomy at age 12 years, a kidney
infection at 16 years, and scarlet fever at 17 years. Following the birth of her first child, she elected to have a tubal
ligation. On examination in April 1977, she appeared to be
of average intelligence, had been graduated from high
school, and was working as a processor at an electrical
equipment plant. She was 149.87 cm tall and weighed 58.9
kg. Dermatoglyphics were normal.
CYTOGtNHIC STUDIES

Case /: Peripheral blood lymphocytes were cultured in
vitro using a slight modification of the method used by
Moorhead et al.' Metaphase chromosomes were stained
with the trypsin-Giemsa chromosome banding technique of
Seabright.' Twenty randomly selected metaphases were
counted, and a modal number of 46 chromosomes was
established. Five cells were photographed and karyotyped
and a large ring chromosome identified as chromosome 9
was present in all cells. Chromosome-banding analyses established the breakpoints at region 2, band 4 in the short
arm (p24) and region 3, band 4 (q34) in the long arm,
indicating that the two breaks were near the terminus of the
short and long arms, 46,XX,r(9)(p24;q34).' A representative karyotype is shown (Figure, bottom left).
C(lse 2: At her own request, cytogenetic studies were
done on the mother of the proband (11,5), the maternal
grandparents (1 , I a nd 2), and the proband's father (11,6).
Normal karyotypes were documented for the maternal
grandparents a nd the proband's fat her; however, a ring
chromosome (9) was found in all cells scored from duplicate
peripheral blood cultures from the proband's mother.
Chromosome banding analysis revealed her karyotype to be
46,XX,r(9)(p24;q34 ). A partial karyotype is shown (Figure,
bottom right).

Discussion
Two aspects of these cases are of particular interest to the clinical geneticist and cytogeneticist. The
first is the de novo origin of a ring chromosome in a
mother with few, if any, phenotypic abnormalities;
and second, the transmission of what appears, cytogenetically, to be the same ring chromosome-structurally unaltered-to her daughter whose major
physical defects are short stature and microcephaly
associated with mental retardation. One could argue
that the ring chromosome is responsible for the phenotype of the affected daughter, or that the ring (9) in
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the daughter and the associated phenotype are unrelated because the mother possesses the same ring.
Ring chromosomes present the clinical geneticist
with a challenging counseling problem be~ause many
aspects of their behavior during meiosis remain obscure. The way in which the ring chromosome participates in genetic recombination during meiosis, the
occurrence or not of sister chromatid exchanges
within the ring, and the subsequent genetic constitution of the ring will all determine whether a balanced
or unbalanced gamete results. Although chromosome
banding analysis allows the definitive identification of
the involved chromosome and the accurate determi·
nation of the points of breakage, genie determinations await the refinement of the human gene map.
It is possible that there is a tissue distribution
difference of the ring (9) in the mother and daughter.
Although only peripheral blood has been examined
to date and no evidence of chromosome mosaicism
documented, tissue mosaicism cannot be ruled out.
We are aware of two other patients possessing a
de novo ring (9) with break points identical to those
in our family, (p24;q34), reported by Fraisse et al,9
and by Y. Nakagome, MD et al (written communication, March 1976). There are many similarities between our patient and Nakagome's patient: proportion ate short stature, prominent nose, microcephaly,
mental and motor retardation, and poor speech development. The dermatoglyphic findings in our patient are of interest in that the finger pattern showed
10/ 10 arches, similiar to the case report of Fraisse et
al, 9 but in contrast to Nakagome's patient in whom
there was a high palmar triradius only.
It is not possible to make definitive phenotypekaryotype correlations based on three clinical cases,
but the following observation can be considered. In
our family, the proband's phenotype could result
from genie alterations associated with the ring
chromosome and the normal phenotype of the proband's mother from a yet-to-be identified tissue mosaicism, or the contrasting phenotypes could be the
result of the hemizygous expression of paternal recessive alleles. It is also possible that only minor genetic
changes occurred at the time of de novo ring formation which the mother inherited. Finally, the potential influence of ascertainment biases in a family of
this type must always be considered. If, for whatever
reason, the ring chromosome is consistent with phenotypes ranging from normal to severely affected,
one would be much more likely to observe severely
affected sporadic cases and mildly affected parents of
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familial cases than to find severely affected parents
with normal children.

5. ZDANSKY R, BUHLER EM, YEST M, ET AL: Familiiires Mosaik
mit G-ring. Humangenetik 7:275-286, 1969.
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The term amyotrophic lateral sclerosis (ALS)
was first introduced by Charcot to describe cases with
mixed upper and lower motor neuron signs without
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sensory impairment. 1 Later, th~ syndromes of progressive bulbar palsy (PBP) and progressive muscular
atrophy (PMA) were recognized to be variations of
the same pathological process, and ALS was used as
an inclusive term to refer to these syndromes as well.
Although some authors reserve the term ALS for the
specific syndrome of mixed upper. and lower motor
neuron lesions and use the term "motor neuron disease" to refer to the constellation of syndromes, most
MCY QUARTERLY 13(4): 182-186, 1977
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Fig I-Pedigree of proband and family members.
* = Age at diagnosis
• = Present age
+ = Age at death

of the literature on familial cases uses ALS as a
generic title. We will adhere to this convention.
Initially, the disease was thought to be sporadic,
with a stable incidence of l in 100,000 population per
year. In the early 1950s, reports appeared of a high
incidence of ALS in the Chamorro Micronesians of
Guam and on the Kii Peninsula in Japan. 2 - 5 Studies
suggested that at least some of the cases of ALS
among Chamorros might be familial, and at about
the same time familial cases began to be reported in
Caucasian populations.
Case Report
Prohand: The proband (Fig I, III-2) is a 55-year-old
white female with known maturity-onset diabetes, hypothyroidism , hypertension, a nd hepa tosplenomegaly diagnosed
as cirrhosis with fatty infiltration on liver biopsy, who presented with a three-year history of progressive weakness in
her legs, causing difficulty in walking upstairs and rising
from a chair. For one year, weakness increasingly impaired
her ability to pick up objects, and her writing had become
illegible. There had been no episodes of acute exacerbation
or remissions.
On examination, wasting and fasciculations of the
tongue were noted, and her speech was slow and slurred,
and the jaw jerk was hyperactive. There was weakness and
wasting in the legs, and all reflexes were brisk with sustained
ankle clonus, bilateral Hoffman signs, and bilateral positive
Babinski responses. Sensation was normal in all modalities.
VDRL, serum B12, cerebrospinal fluid (CSF), myelogram ,
and computerized axial tomography (CT) scans were all
normal. An electromyogram (EMO) showed changes consistent with ALS, especially in the C, and T, nerve root
distributions.
Other Family Members: It can be seen from the pedigree (Fig I) that the pro band's mother (II-3), maternal

aunt (11-4), cousin (III-10), niece (IV-2), and two brothers
(III-I , III-8) have all been diagnosed as having ALS. The
age a.t onset has been variable, as has the duration of the
disease in the different family members.
The offspring of the proband are presently under investigation. The eldest son (IV-3) has definite upper motor
neuron signs in the legs with brisk reflexes and bilateral
Babinski responses which, combined with the family history, are highly suggestive of ALS. Two offspring (IV-4 and
IV-5) show minimal signs of muscle wasting and slightly
brisk reflexes. The diagnosis of ALS here is less certain, but
the possibility exists that these two brothers are also affected. The two youngest children (IV-6 and IV-7) show no
sign of the disease. EMO studies may help establish a
definite diagnosis in those family members at risk.

Discussion
Evidence for Heterogeneity in ALS
There are three recognizable clinical forms of
classical, sporadic ALS. In progressive bulbar palsy
(PBP), muscles innervated by the medulla are primarily affected. The presenting symptoms are dysarthria and dysphagia of insidious onset. The tongue
atrophies and shows conspicuous fasciculations. Palatal involvement is indicated by progressive speech
difficulties and regurgitation of food through the
nose. Whereas PBP is the result of a lower motor
neuron (LMN) lesion, it is frequently accompanied
by upper motor neuron (UMN) involvement of the
cranial nerves leading to "pseudobulbar palsy." Here
the tongue is again small but tends to be spastic, and
the jaw, p alatal, and pharyngeal reflexes are exaggerated. In addition, there is marked emotional )ability
with attacks of inappropriate laughing or crying.
In a second form of the disease, muscles in-
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nervated by the spinal nerves are primarily affected
and UMN signs accompany those resulting from the
lesions of the LMNs. Isolated UMN lesions are indicated by spasticity and brisk reflexes with bilateral
Babinski responses, whereas isolated LMN lesions
present with muscle wasting, weakness, and fasciculations with depressed or absent reflexes. The actual
physical signs depend on the relative preponderance
of UMN or LMN degeneration.
In a third form, LMN lesions predominate resulting in progressive muscular atrophy, but UMN
lesions may occasionally be present. The symptoms
and signs of LMN lesions are as described above and
usually start in the hands and forearms .
Although these three clinical presentations can
be distinguished, all are thought to be variations of
the same process. Sensory impairment is not found,
although patients may complain of muscle cramps or
abnormal sensations resulting from muscle fasciculations.
The diagnosis is usually made on clinical
grounds, although the EM G shows characteristic
patterns of denervation with fibrillation, fasciculation, and giant action potentials indicating spontaneous activity.
Pathologically, extensive neuronal loss is evident
with astrocytic gliosis of the UMNs and LMNs as
well as the lower cranial nuclei. Cytoplasmic and
nuclear shrinkage occurs with excessive accumulation
of lipofuscin. In Guamanian cases, additional features include neurofibrillary degeneration of the orbital gyrus, Ammon horn, and basal ganglia. Granulovascular bodies are a lmost always present in the

pyramidal cells of Ammon horn where eosinophilic
crystaloid inclusion bodies are also seen. 6
Although reports of familiai adult-onset ALS
constitute only about 5% to 10% of the reported
cases, 7 at least 30 Caucasian families have been described in which then:: appears to have been a dominant mode of inheritance.8 - 16
Among the Chamorros, nearly 50% of all reported cases are familial; 17 however, extensive studies
have failed to define a clear pattern of inheritance. 7 It
is possible that there may be a genetic predisposition
to an environmental agent.
It is still uncertain whether these three entities,
sporadic, Guamanian, and fami lial ALS, represent
one or several etiologically different diseases. All
three present with indistinguishable symptoms of
muscular atrophy, lateral sclerosis, and bulbar palsy.
Dementia, often seen in affected Chamorros, also
occurs in both familial and sporadic cases. 18 Involvement of the posterior columns has been described in a small number of inherited ALS cases 19
but not with enough consistency to be distinctive.
Other parameters may permit a clear distinction
of the three types (Table l ).
Sporadic ALS typically has a iate onset in the
early 50s; the first signs usually appear in the upper
extremities, and the disease has a short duration leading to death within five years. In contrast, a review of
30 published Caucasian pedigrees indicates that familial cases more often have an onset in the early
forties beginning in the lower extremities with a
longer duration. Chamorro cases resemble familial
ALS in onset and duration but are similar to sporadic

TABLE I
Comparison of Sporadic, Guamanian, and Familial ALS
Sporadic

Based on
Age of onset, yrs
Onset under 30 yrs
Duration, yrs
Duration > 5 yrs
Initial Site
Bui bar
Upper extremity
Lower extremity
Other
Sex ratio: male: female

Parameter value
52.7 ± 2.7
1%
2.5
8.1 %

Number of
cases

JOO
100
86
86

Parameter value
46.1 ± 13. 1
8%
4
34.3%

JOO
25%
41 %
30%
4%
1.86: I

Familial

Guamanian
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13%
64%
20%
3%
1.94: I

Number of
cases
62
62
70
70
62

132

Pa rameter value
42.7 ± 11.1
13.3%
4.3
36.5%
18%
26%
56%
0%
1.13: I

Number of
cases
98
98
83
83
70

98
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Fig 2-Cumulative distribution of age at onset in familial ALS.

ALS in sex ratio and site of initial involvement. 17 • 20
The Chamorro population on Guam appears to be
intermediate in many respects between the familial
and sporadic types. However, until the etiology of
ALS is known, it will not be possible to classify these
diseases with certainty.
Genetic Counseling
In this family, the pedigree suggests autosomal
dominant transmission with complete penetrance,
but in the absence of male-to-male transmission, a
sex-linked dominant inheritance cannot be excluded.
The genetic a dvice given to family members (consultands) will depend on the presence or absence of signs
of the disease and their relationship to individuals
known to be affected.
For example, a 47-year-old man, whose father
has been diagnosed as having A LS, wants to know if
he too will become affected and what is his risk of
having an affected child. His a priori risk of having
inherited the gene from his father is one half because
of the dominant transmission of ALS. From a review
of published familial cases, ALS appears to be a

TABLE 2
Bayesian Approach to Estimation of Genetic Risk

Probability
A priori
Co nditional
Joint
Posterio r probability
the consultand
is affected

Inherited the
disorder

Not inherited
the disorder

1/ 2
1/ 4
1/ 8

1/ 2
I
1/ 2
1/ 8
- - - - - = 1/ 5
+ 1/ 2
1/ 8

strongly penetrant trait with nonpenetrance occurring in only 3% of the cases. 18 •2 1 Figure 2 depicts a
cumulative distribution of the age of onset of familial
ALS in 52 males and 46 females culled from the
literature. Patients who do carry the gene have only a
one-fourth probability of reaching the age of 4 7 without manifesting the disease. The posterior or final
probability that the consultand, age 47 with an affected father but no symptoms himself, will develop
ALS is one fifth or 20% (Table 2). 22 The practical
implication for genetic counseling is that the longer
the consultand lives and is symptom free, the lower
will be his risk of carrying the gene.
Conclusion
Familial conditions, such as ALS, Huntington
chorea, dystrophia myotonica, polyposis coli, and the
presenile dementias, in which individuals who carry
the abnormal gene may not develop symptoms until
late in the reproductive period, present difficult problems for the genetic counselor. Modification of the a
priori probabilities by consideration of the age of the
consultand, as described above, can make a considerable difference to risk estimates.
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A Case of Saethre-Chotzen Syndrome
CATHERINE McKEON-KERN, Graduate Assistant, Department of Human Genetics
PETER MAM UN ES, M.D., Professor of Pediatrics and of Human Genetics

Saethre-Chotzen syndrome was described independently by the Norwegian psychiatrist, Saethre, 1
and the German psychiatrist, Chotzen, 2 in the 1930s;
Correspondence and reprint requests to Catherine McKeonKern , Box 33, Medical College of Virginia, Richmond, Virginia
23298.

since that time many cases have been reported, some
using the terms acrocephalosyndactyly, type III, and
craniooculodental syndrome. Clinically, the syndrome is characterized by premature closure of the
cranial sutures, low-set hairline, nasal septum deviation, brachydactyly, and ptosis. 3 It is inherited as an
autosomal dominant with complete penetrance and
MCV QUARTERLY 13(4): 186-188, 1977

MCKEON-KERN AND MAMUNES: SAETHRE-CHOTZEN SYNDROME

187

Figure-(a) Skull x-ray at 6 months reveals difference in orbit size and asymmetric shape of skull. (b) Left profile shows abnormal
placement of ear and flat nasal bridge. (c) Patient at 6 months has left-sided ptosis, dystopia canthorum, and short palpebral fissures.
Face shows characteristic asymmetries with left side being affected.

great variability in expression. Because of this variable in expressivity, the syndrome is difficult to diagnose in the less severe form without a positive family
history.
Recently, an infant was admitted to the Medical
College of Virginia newborn nursery who had many
of the features of Saethre-Chotzen syndrome, as well
as other findings which have rarely been reported in
association with the syndrome.
Case Report
The patient is a black female infant who was born five
weeks prematurely to a 17-year-old para 1, gravida 1
mother and a 23-year-old father. She weighed 1,830 gm and
had a 27.5 cm head circumference at birth. At four weeks,
she was transferred to the MCV Hospital with Group BBeta streptococcal sepsis which was successfully treated
with a ten-day course of penicillin and. gentamicin. On
admission, she was noted to have facial asymmetries, ptosis,
hypertonia and a probable ventricular septa! defect; she was
referred for a genetics consultation.
Her family was evaluated for stigmata of SaethreChotzen syndrome. The child's father was unavailable for
examination but was reported as having a face that was
slightly asymmetrical with an under-developed left cranium
and the left eye smaller than the right. These asymmetries
were said to be more pronounced in childhood. The mother
was examined and did not show any stigmata of the syndrome. No other family members were known to be affected.
The physical examination of the child revealed an acrocephalic skull with left-sided malar, frontal and anterior
parietal bone hypoplasia, and microcephaly. Her face was
asymmetric with left-sided ptosis; she had dystopia with

generally small palpebral fissures, the left slit being shorter
than the right. Her nasal bridge was flat, her ·nose had a
broad tip and a long prominent philtrum, and her mouth
was thin and down-slanting. The left ear was lower than the
right and posteriorly rotated, but both ears were well
formed. Her neck was short a nd displayed a decreased
range of motion, though it appeared normal on x-rays. Her
hips also displayed a 20 degree decrease in motion. She had
two cafe-au-lait spots; one 2 X 3 cm on her back and one 2.5
cm in diameter in the groin area. There was a sacral dimple
on her lower back. She had a grade IV/ VI systolic murmur,
probably caused by a ventricular septa! defect.
Her extremities were slightly asymmetrical with the
right arm and leg 0.5 cm longer than the left. She had two
dimples on either side of each elbow and knee, a peculiar
long longitudinal skin crease along both inner calves, and
mild hallux valgus.
A dermatoglyphic analysis revealed an excess of whorls
(six), one of which was a radial loop with a central pocket.
She had an intermediate triradius. Both the a-b ridge count
and the total finger ridge count were within normal limits.
X-rays of her skull and hips in the neonatal period were
read as normal except for a normal variant of a lilckenschadel deformity of the skull. Repeat x-rays of the skull at
6 months showed I) cranial asymmetry with the left orbit
smaller than the right, 2) coronal sutures that were patent
but narrower than the other cranial sutures, and 3) a left
temporal bone that was higher than the right (Figure-a). Xrays of the cervicothoracic spine at that time were normal.
Chromosome analysis showed a normal fem ale karyotype,
and her serum calcium of 11 mg/ 100 ml was normal at 6
months.
A follow-up examination at age 8'1i months showed all
her physical measurements to be below the 3rd percentile
with a length of 63 cm, weight of 13 lb 12 oz, and head
circumference of 39.5 cm. She was generally hypertonic and
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had poor head control. However, her motor milestones
were not delayed ; she was able to crawl and transfer objects
from hand to hand by 8 months and sit without support at
the age of 9 months.
From these physical and radiological findings the diagnosis of SaethrecChotzen syndrome was made.

Discussion
The physical findings of 120 cases of SaethreChotzen syndrome were compared by 0. A. Pantke
et al. 4 In facial appearance the patients were strikingly similar to each other and to our patient. More
than 75% had ptosis, deviated septum, acrocephaly,
and low-set frontal hairline. The facial asymmetries
and unusual cranial contours in the syndrome probably result from premature closure of the coronal or
sphenobasilar sutures. This may also account for the
tear duct stenosis and the mild mental retardation
which are occasionally found . Skull x-rays like the
ones in this case are characteristic, showing premature closure of the sutures as well as asymmetries
in bone and orbit size. Hypertelorism and dystopia
canthorum are often observed. Optic atrophy may be
an associated finding.
The ears are frequently small and low-set, with
folded pinnae. Conductive hearing loss is an occasional finding. The palate is either high-arched or
clefted. Dental anomalies such as missing teeth and
peg-shaped or anomalous maxillary lateral incisors
are important in differientating this syndrome from
the other acrocephalies.
The extremities may show mild syndactyly;
brachydactyly is common . Clinodactyly and hallux
valgus are sometimes noted.
The cardiac defect our patient exhibits is rarely
found in Saethre-Chotzen syndrome; however, it was

reported in Chotzen's original cases and in several
individuals of another kindred. 5
The multitude ofassociated findings in this syndrome can not be explained on the basis of premature
closure of the sutures alone, though this does account
for m.any of the facial features. Other malformations
such as the cardiac defect, dental anomalies, and
defects of the extremities indicate that one gene has
varied effects on many organ systems.
Our case further documents the association of
cardiac defects with Saethre-Chotzen syndrome while
also demonstrating many of the characteristic findings. The child's father probably represents a very
mild expression of this dominantly inherited condition, demonstrating the wide variability of expression
seen in this disorder.
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A New Familial Chondrodystrophy
Simulating Parastremmatic Dwarfism
WENDY L. GOLDEN, Graduate Assistant, Department of Human Genetics
PETER MAM UN ES, M.D., Professor of Pediatrics and of Human Genetics
MICHAEL B. KODROFF, M.D., Assistant Professor of Radiology

Recent developments in tissue culture and enzyme analysis have made it possible to classify more
precisely some of the skeletal dysplasias and to understand their pathophysiology; thus almost all seven
clinical types of mucopolysaccharidoses are due to
separate single enzyme deficiencies-one type, the
Sanfilippo syndrome, has three subtypes, each with a
different enzyme deficiency.' The majority of the skeletal dysplasias have no definable biochemical abnormality a nd are classified on the basis of clinical and
radiological findings and the mode of inheritance.
The purpose of this report is to present a family with
an apparently new type of chondrodystrophy.
Case Report
Proband: An 18-year-old male with a diagnosis of Morquio disease was brought to the Medical College of Virginia
Genetic Counseling C linic by his mother and sister. He was
the product of a normal, unco mplicated pregnancy, labor,
and delivery, and at birth was considered normal. At age 3
to 4 months his mother states that he appeared to be behind
in his development, although he was said to have had a
three-word vocabulary at 5 months a nd at IO months could
put three words together in a sentence. He was evaluated at
2 112 years and found to have mild kyphosis o f the dorsolumbar region, moderate genu valgus, and slight restriction of
internal a nd external rotation, and extension, of both hips;
the sternum was rioted to be particularly prominent. Radiographic examination showed slight diffuse changes of chondrodystrophy throughout, with the changes in the spine
appearing more marked (Figure, b,f). He as unsuccessfully
fitted with braces in an effort to make him ambulatory.

This work was supported in part by Grant #9306-5124 from
The National Foundation-March of Dimes.
Correspondence and reprint requests to Wendy Golden, Box
33, Medical College of Virginia, Richmorid, Virginia 23298.
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The skeletal changes progressed a nd when first seen at
the MCV C linic in 1976, the patient was markedly dwarfed
(length 36 1/2 inches), with coarse facies showing hypertelorism, a flat, wide nasal bridge, anteverted nostrils, a lack
of cartilage in the nose and ears, heavy eyebrows; strabismus, and searching nystagmus. There .was no corneal
clouding. There were marked contractures of the limbs with
limited movement in all directions of the knees and hips.
The wrists were thickened but otherwise normal. The fingers
were hyperextensible and the metacarpal' joints appeared
enlarged. Extension of the left elbow was nearly normal,
while t he right elbow had a 20 degree limitation of extension. All of the joints appeared knobby and enlarged, accentuated by the thinness of the extremities (Figure, e). There
was severe kyphosis with mild thoracolumbar scoliosis and
the sternum protruded anteriorly to a very marked degree
(Figure, d). Also noted were signs of trunk a nd upperextremity ataxia. While in the hospital he showed marked
difficulty in breathing, with wheezing a nd congestion. There
was no hepatosplenomegaly nor an abnormality of the palate.
There appeared to be moderate psychomotor retardation with disproportionate speech impairment, but mentation was difficult to assess due to the difficulty in speech
and the lack of formal education.
The skeletal survey revealed ma rked kyphoscoliosis of
the entire spine with a universal platyspondylia without
anterior beaking of the vertebral body. The end plates were
markedly irregular with lacelike ossifications. No evidence
of rhizomelia could be demonstrated. There were marked
changes about the knees with flaring of the metaphyses and
marked irregularities of the ossification centers, both metaphyseal and epiphyseal, with the same lacelike ossification
seen in the spine (Figure, g). Films of the pelvis revealed
shortening of the ilium bilaterally, with the same irregular
lacelike ossification bordering the iliac bones and around
the joint spaces (Figu re, c). Marked deformities were present
in the feet. A ll of the actively growing centers showed the
same type of changes as the knees. There was no significant
bowing of the long bones. The skull showed a marked
thickening of the calvarium, both over the convexities of the
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Figure-(a) Pedigree of family. (b.c) Pelvic x-rays of pro band showing dramatic changes from 2 1/2 to 18 years, with development of a lacelik e
ossification pattern. (d,e) Clinical appearance ofproband at 18 years. (f.g) X-rays of knees at 2 1/2 and 18 years. Note the development of
marked flaring of epiphyses and metaphyses and lacelike ossification.
skull and at the base. A midline tomogram revealed the
presence of basilar impression. These findings were felt to
be inconsistent with a diagnosis of Morquio disease or any
other spondylometaphyseal dysplasia.
Blood studies on the proband showed no unusua l findings except for mild borderline anemia and an increase in
platelets. An SMA 6 was within normal limits. SMA 12 was
normal except for an increase in alkaline phosphatase. Urinalysis was within normal limits. An electrocardiogram
showed a generalized grade I dysrhythmia, but the study
was reported to be a technically difficult recording due to
movement. Hearing sensitivity was within normal limits,
with a bilateral 20-decibel hearing loss. A pulmonary lab
report noted the presence of severe hypoxemia and moderate metabolic acidosis which was uncompensated.
An enzyme analysis of skin fibroblasts, (courtesy Dr.
Thaddeus Kelley), showed normal levels of fucosidase,
mannosidase. /3-galactosidase, hexosaminidase, arylsu!fatase, and a-iduronidase. On two runs of radioactive sulfate
accumulation the cultures from the proband were similar to
the controls.

Other Family Members: An investigation of the family
history revealed two other relatives, a brother and a maternal uncle, who appear to have had the same disease as the
proband (Figure, a). Further, it appears that the proband's

mother is mildly affected, and a maternal au nt and maternal
grandmother may show minor signs of the disease.
The proband 's brother was born in 1954 after a normal, uncomplicated pregnancy, labor, and delivery. H ~}t!t
alone at 6 months, but walking was delayed until 18 morit_H§
and even then he had trouble with his balance. A diagnosis
of rickets was made at about 1 to 2 years of age and he was
admitted to a children's hospital in 1958 for evaluation of
his deformities. Physical examination revealed severe kyphosis in the low dorsal and upper-lumbar spine and
marked genu valgus with enlargement of the knee joints.
Motion through the hip joints was slightly restricted in
external and internal rotation and in extension. The radiologist's report stated that there was " generalized disease of
cartilaginous development," and that the changes seen were
consistent with a diagnosis of Morquio disease. The patient
was seen again in 1961 at which time he was ambulatory;
however, the deformities about the knees had increased as
h_a d the ky~hosis. He was attending school and was reported .tb be doing well. A physical examination following
admission to a hospital for respiratory stridor in 1970 noted
him to be a grossly skeletally deformed dwarf (height 40 in;
weight 60 lb), with coarse facies, ocular hypertelorism, flaring of the alae nasae, saddle nose, pectus carinatum, and
marked kyphoscoliosis. There was darting nystagmus but
no corneal clouding. He was treated unsuccess.fully with

GOLDEN ET AL: FAMILIAL CHONDRODYSTROPHY
aminophylline and died three days after admission, the
cause of death being listed as terminal cardiorespiratory
failure with interstitial pneumonia of viral etiology.
The proband' s mother is a 51 -year-old woman with
coarse features and difficulty in walking. Her height is 62 in.
Radiographs in 1976 showed mild degenerative changes in
the distal phalanges of the hand and in the body of T-12 as
well as partial collapse of the latter. Accentuated lordosis of
the lumbosacral spine was noted with anterior lipping and
mild degenerative changes. There was deformity of the feet
with pes cavus bilaterally. The long bones showed early
degenerative changes about the hips. The iliac bones were
shortened and there was flattening of the acetabular roof.
These changes were similar to, but much less severe than,
those found in her son.
The proband' s mother reported that she had had a
brother, born in 1929, who was affected similarly to her two
sons. He appears to have followed the same clinical collrse
and died in 1950, reportedly from the same type of illness as
his deceased nephew.
Also noted in the family history is a maternal aunt who
walks with difficulty, although she is reported to be of
normal height; the maternal grandmother has the same type
of walking difficulty. The proba nd's two sisters, who have
two different fathers, are of normal height and appearance
and present a striking contrast to their mother.
The family history is very suggestive of X-linked inheritance, with the males being affected more severely than the
females.

Discussion
On the basis of radiographic, biochemical, and
ophthalmologic findings, Morquio disease and the
other mucopolysaccharidoses were eliminated fro'm
the diagnosis.' Of the spondyloepiphyseal dyspla~j 4~
(SED), 2 SEO congenita, and SEO tarda anq SQf
tarda brachyolmia type were considered. SEQ cq[]~
genita is an autosomal dominant in which the".geformities are present at birth and it is further differentiated from this case by its characteristic presence of
rhizomelia and retinal detachment. SEO tarda is a
relatively mild form of X-linked recessive dwarfism in
which the age of onset is between 5 to I 0 years of age.
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SOT brachyolmia is also a mild form of dwarfism in
which the skeletal deformities are not consistent with
the radiographic findings in this case. None of the
mucopolysaccharidoses nor the SEDs show the striking lacelike ossification described in our patient.
Parastremmatic dwarfism 3· ' was considered because of the distinctive Iacelike ossification of the
bones; however, in a written communication, in February, 1977, with Dr. Langer, who first described
parastremmatic dwarfism, it was noted that our patient did not have the classic twisting or bowing of the
long bones. The essentially normal configuration of
the proximal femora and the type of changes seen in
the vertebral bodies differentiate this case from parastremmatic dwarfism which is considered to be an
autosomal dominant disease.
We feel that this patient represents an X-linked
form of dwarfism, not previously described, which is
characterized by coarse facies, severe skeletal deformities involving nearly all bones, and a distinctive
lacelike ossification of the iliac bones, the end plates
in the spine, and the epiphyses and metaphyses of the
knees and elbows. In such cases neurologic and cardiopulmonary complications lead to. demise in late
adolescence or early adulthood.
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Familial Occurrence of Pierre Robin
Anomalad
WENDY 0. SEGRETI, M.A., Graduate Assistant, Department of Human Genetics
PETER MAM UN ES, M.D., Professor of Pediatrics and of Human Genetics

The Pierre Robin anomalad is a congenital defect consisting of micrognathia, glossoptosis, and
cleft palate. While these three stigmata represent the
classical triad of anomalies first described by Pierre
Robin in 1923,1 less severe forms of the anomalad are
seen with a variable expression of the microsigns of
the disease. Dennison 2 suggests that the determination of exactly what constitutes a mild degree of
Pierre Robin anomalad is a subjective matter. While
cleft palate is commonly present, it may sometimes be
replaced by a high-arched pahite. He reports that
radiography shows that there is a short mandibular
body joining the ramus at a more acute angle than
normal. The more severe cases can lead to respiratory
obstruction and death. Anatomically, the defect is
q4ite clear; th~ body of the mandible is posteriorly
displaced causing the tongue to block normal respiratory and alimentary pathways.
No mode of inheritance has yet been clearly
established. While the majority of cases of this rare
disorder (I :50,000 births )3 appear to be sporadic,
there have been several reports of familial occurrence; cases of affected brothers have been presented 4•
5 and an X-linked subvariety exhibiting persistence of
the left superior vena cava and atriill septa) defect has
been described. 6 A family having maternal half-siblings with the Pierre Robin anomalad is reported
here. The mother bore a single affected male and four
normal females by her first husband and two affected
females by her second husbanq. Strong evidence exists for dominant transmission through the mother,
who herself exhibits mild characteristics of the dis-
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order. We therefore propose that this family represents an autosomal dominant form of the Pierre
Robin anomalad with variable expressivity.

Case Report
The proband (Fig I , III,!) was born on July 22, 1976,
of a 26-year-old mother and a 25-year-old father. She was
the 8 pound IO V2 ounce full-term product of a pregnancy
complicated by maternal vaginal discharge which was
treated with a cream and resolved in the second trimester,
and leaking of a mniotic fluid with spontaneous resolution
from the fourth through the sixth months. The patient was
born by a normal vaginal delivery, cried immediately, and
did not need resuscitation. Midline cleft palate and micrognathia were noted at birth, with the lips intact. Other than
two left preauricular skin tags and possible bilateral high
frequency hearing loss, no other abnormalities were present. She breathed rapidly and became cyanotic when allowed to lie flat on her !Jack with resulta nt backwa rd displacement of the tongue. Postnatal jaundice was treated
with phototherapy. She was discha rged with special feeding
instructions, but readmitted a month later due to poor
weight gain. At two months she was noted to have a grade I

I
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Affected

Minor manifestations

Fig I-Pedigree of pro band's family showing affected half-siblings.
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aorta in addition to the Pierre Robin anomaly. Of the four
normal half-sisters of the proband (Fig I, III,4,5,6,7), two
have slightly high , narrow palates and small chins. The
mother has a very high-arched palate and micrognathia. A
lateral x-ray of the mother's jaw demonstrated that one
ma ndibular ramus was smaller a nd narrower than the
other, presenting as asymmetrical appearance, a nd the
mandibular angle was steeper than normal (Fig 2).

Discussion
We have presented a family in which three children (I male and 2 females) who had two different
fathers were affected with the Pierre Robin anomalad. The mother exhibits some of the characteristic
stigmata of this syndrome which strongly suggests
that an autosomal dominant form of the Pierre
Robin anomalad exists with variable expressivity.
REFERENCES
Fig 2-Lateral x-ray of proband's mother showing steep mandibular a ngle.
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to II/VI systolic ejection murmur, but chest x-ray, electrocardiogram, a nd a cardiology consultation suggested
that there was no organic heartdisease present. The patient
was hospitalized many times during the first months of life
due to multiple episodes of pneumonia and the inability to
maintain adeq uate nutrition. At age 7 months a tracheostomy was done which resulted in improved breathing
and weight gain. At age 11 months the patient was admitted
for bronchoscopy and removal of the tracheostomy tube;
she was unable to breathe adequately without it, and the
tube was rein serted. She died suddenly at the age of one
year, but no postmortem examination was permitted.
The proband's sister (Fig I , IIl ,2), also affected with
Pierre Robin a nomalad, died two months after birth as a
result of poor weight gain a nd a terminal bout of aspiration
pneumonia. Their half-brother (Fig I, III ,3), who died 28
days after birth, had severe congenital heart disease, including persistent left superior vena cava, tricuspid atresia,
atrial septa! defect, right-sided aortic a rch, and descending
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